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Abstract 
Abdominal aortic aneurysm (AAA) is a dynamic vascular disease characterized 
by inflammatory cell invasion and extracellular matrix (ECM) degradation. Evidence has 
demonstrated a profound influence of genetic background on AAA formation. The work 
presented herein discusses two studies: the first demonstrates how genetic components 
can enhance the susceptibility to AAA formation and the second demonstrates how ECM 
degradation enhances AAA progression by influencing inflammatory cell phenotypes. An 
understanding of the pathways involved in AAA pathogenesis can help not only to 
identify potential patients at risk of AAA development, a heritable disease in which the 
incriminating component has yet to be discovered, but also to identify therapeutic targets 
for medical therapy. By using the CaCl2 model of aneurysm formation, we were able to 
induce aneurysms in two different strains of mice, C57Bl/6 and 129/SvEv. While both 
strains developed aneurysms, 129/SvEv mice developed larger aneurysms, increased 
inflammatory cell infiltration, and had higher MMP expression compared to C57Bl/6 
mice. We believe this increased susceptibility is due to increased ProMMP-2 expression 
at baseline. This increase in MMP expression may help to explain why some patients 
develop aneurysms at faster rates than others or why some patients may be 
predisposed to aneurysm formation while others form atherosclerotic plaque.  
Furthermore, our study examines how products released from damage to the 
aortic wall, particularly the breakdown of elastin and the release of elastin-derived 
peptides (EDPs), influence the surrounding microenvironment. Pro-inflammatory M1 
macrophages initially are recruited to sites of injury but, if their effects are prolonged, can 
lead to chronic inflammation that prevents normal tissue repair. The EDPs released from 
aortic wall damage create a pro-inflammatory M1 macrophage phenotype. By using 
CaCl2 to induce AAA formation, we show how manipulation of this pro-inflammatory 
response by direct injection of anti-inflammatory M2 macrophages can reduce aortic 
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dilation. Antibody-mediated neutralization of EDPs can attenuate aortic dilation by 
preventing macrophage recruitment to the damaged aortic wall, reducing MMP 
upregulation, and influencing the M1/M2 phenotype ratio. By manipulating the M1/M2 
ratio, we identify a potential therapeutic target in the fight to discover a medical therapy 
and minimize the need for invasive mechanical intervention in AAA.   
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INTRODUCTION 
Abdominal aortic aneurysms (AAAs) are permanent dilations of the abdominal 
aorta that, if left untreated, can lead to fatal aortic rupture. Death results from 
exsanguination into the retroperitoneum or abdominal cavity and may be rapid. 
Approximately 15,000 deaths due to aneurysm rupture are reported each year in the 
U.S. 1 Most AAAs are diagnosed serendipitously since they are asymptomatic until the 
time of rupture. Therefore, screening programs have been employed to identify the 
disease in high-risk populations. 2 Risk factors include male gender, increased age (> 65 
years), and a positive family history. 3-5 Additionally, smoking history is one of the major 
risk factors associated with aneurysm formation.  A positive smoking history predicts a 
larger aneurysm size at diagnosis6 as well as a higher risk of aneurysm progression with 
continued smoking. 7 Other associated risk factors for AAA formation include Caucasian 
race, presence of other aneurysms, and atherosclerosis.8,9 
An aortic aneurysm is defined as a 50% increase in aortic diameter. Many 
screening studies use an infrarenal aortic diameter greater than 3.0 cm to define an 
aneurysm. Surgical intervention is not recommended until the aorta reaches a diameter 
of 5.5 cm in men and 5.0 cm in women, where the risk of rupture exceeds the risk of 
repair. Currently, there are no pharmacological therapies for slowing AAA progression, 
so patient management is a matter of watching and waiting until the aorta reaches a size 
where repair is indicated. Animal studies using statins, β-blockers, angiotensin-
converting enzyme inhibitors, angiotensin receptor blockers, and tetracyclines have 
been shown to have a beneficial effect by delaying progression of aortic dilation. 10-17 
Despite this, none of these drugs have proven benefit in humans. The only known 
approach to slow aneurysm progression is smoking cessation.  
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The pathogenesis of AAA is a highly complex process that is undoubtedly 
multifactorial with, an as yet uncertain, genetic contribution. Histological features of AAA 
include smooth muscle cell (SMC) apoptosis, elastin fragmentation, as well as chronic 
adventitial and medial inflammatory cell infiltration. 18 Elastin fragmentation is triggered 
by upregulation of various elastin-degrading enzymes such as matrix metalloproteinases 
(MMPs), cysteine proteases, and serine proteases. These elastin and extracellular 
matrix (ECM) fragments recruit inflammatory cells to the artery wall triggering an innate 
immune response that attempts to resolve the damage. The adaptive immune response 
later develops and is associated with aneurysm progression through antigen specific 
antibody production. 19,20  
Studies of human aortic aneurysm tissue obtained at surgery are informative but 
likely reflect the end stage of the disease process. To investigate the cause of 
aneurysmal disease and to determine early pathophysiological changes in AAA, animal 
models are commonly used. Studies with animal models have led to advances including 
recognition that chronic inflammation, increased expression of endogenous proteinases, 
degradation of structural matrix proteins, and medial smooth muscle cell depletion all 
play a role in the process of aneurysm development. 21,22 Genetically engineered mice 
have been increasingly used to investigate the molecular mechanisms of AAA.  
Important insights pertaining to inflammatory cytokines and MMPs have been obtained 
from mouse studies involving targeted disruptions of genes such as interferon-γ (IFN-γ), 
tumor necrosis factor-α (TNF-α), MMP-2, and -9.	  23-­‐26  
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CHAPTER 1 
 
Inflammatory cell phenotypes in AAAs  
 
 
The following is a modified version of an article published in Arteriosclerosis, 
Thrombosis, and Vascular Biology 2015 Aug;35(8):1746-55. The work was coauthored 
by Melissa K Ruhlman, B. Timothy Baxter, and myself. 
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Brief review: Innate and adaptive immune system  
The immune system is a complex arrangement of many cell types and molecules 
interacting to maintain homeostasis. The first basic distinction is the difference between 
innate and adaptive immunity. The innate immune system comprises all of the immune 
responses present from birth whereas the adaptive immune system consists of those 
responses generated after exposure to specific new antigens. The innate immune 
system is considered the first line of defense against invading microorganisms and is 
made up of the cells and molecules that act as first responders in the face of an insult. 27 
It has been conserved throughout evolution with similar molecular components found in 
simple eukaryotes and more complex organisms including humans. 27 The adaptive 
immune system developed later in evolution and can acquire what is considered 
immunologic “memory.” After exposure to a novel pathogen, the adaptive immune 
system tailors its response while maintaining self-tolerance (except in autoimmune 
diseases). These responses are typically controlled with an acute phase and subsequent 
resolution. In aneurysmal disease, it is believed that there is ongoing, poorly regulated 
inflammation resulting in progressive tissue damage and aneurysm expansion.  
 
Inflammatory cells in AAAs 
The transmural inflammation seen in AAA involves a variety of inflammatory cell 
types, where macrophages and lymphocytes are the most prominent with mast cells and 
neutrophils migrating to a lesser extent. 28-31 Ocana et al. demonstrated that both T- and 
B-lymphocytes are present in AAA tissue, where the majority of the infiltrating 
lymphocytes are cluster of differentiation four positive (CD4+) T cells. 32 No natural killer 
(NK) cells were detected in tissue from AAA patients; 32 however, peripheral blood levels 
of NK cells were significantly higher in AAA patients compared to controls. 33 The 
presence of B- and T- lymphocytes suggests antibody-mediated humoral immunity and 
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potentially an autoimmune process driving AAA formation or progression. Previous 
animal studies have reported that without the presence of CD4+ T cells, AAA formation 
does not occur. 34 Furthermore, experimental AAA formation is mediated by interleukin 
(IL)-17, a cytokine notably produced by pro-inflammatory CD4+ T cells. 35 These pro-
inflammatory CD4+ T cells exacerbate AAA disease progression and play a role in 
creating chronic inflammation in the damaged aortic wall (Figure 1.1).  
Macrophages have also been shown to play a key role in AAA progression. 
Macrophages are key components of the inflammatory process. Tumor necrosis factor 
(TNF)-α, IL-6, IL-1β, and interferon (IFN)-γ are pro-inflammatory macrophage-associated 
cytokines studied as biomarkers of AAA progression. 36,37 Although all of these cytokine 
levels are elevated in patients with AAA compared to controls, only IFN-γ levels had a 
positive correlation with AAA progression. Macrophages are recruited to injury sites by 
ECM degradation products and numerous chemokines. These chemokines, monocyte 
chemotactic protein (MCP)-1, IL-8, and TNF-α, are colocalized to infiltrating 
macrophages. 38-40 Macrophages recruited to AAA tissue begin a positive feedback loop 
creating chronic inflammation, but they may not always be harmful in AAA development 
(Figure 1.1). Macrophages, like T cells, display plasticity and have the ability to polarize 
to various phenotypes, such as the classically activated (M1) phenotype or the 
alternatively activated (M2) phenotype. M1 macrophages are typically characterized by 
pro-inflammatory cytokine production and initiate tissue degradation, whereas M2 
macrophages are implicated in inflammation resolution and tissue repair. An M1/M2 
imbalance may be occurring in AAA, where strategies targeting a stronger M2 response 
may prove a potential therapeutic target to reduce chronic inflammation in AAAs. 
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Figure 1. Schematic representation of inflammatory cell infiltration in AAAs. A 
normal aorta is represented on the left with intact endothelial and elastin layers. The wall 
of the aneurysmal aorta consists of robust inflammatory cell infiltration. T cells and 
macrophages primarily migrate to the adventitia, with lesser infiltration into the media. 
Pro-inflammatory Th1 and Th17 cells predominate whereas infiltration of anti-
inflammatory Tregs and Th2 cells occurs to a lesser extent. A macrophage phenotype 
imbalance exists with more pro-inflammatory M1 macrophages (M1 MΦ) than anti-
inflammatory M2 macrophages (M2 MΦ) in the aneurysmal aortic wall. During the initial 
aortic growth phase, thickening of the adventitial layer occurs, resulting in increased total 
wall thickness. Aneurysm formation and inflammation results in breakdown of medial 
elastin and smooth muscle cell (SMC) apoptosis, causing a thinning of the medial layer. 
Loss of the endothelial cell (EC) layer is replaced by an intraluminal thrombus (ILT).  
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Inflammatory cells in atherosclerosis 
 Atherosclerosis is an inflammatory disease beginning in the intima of large and 
medium sized arteries caused by accumulations of low-density lipoproteins (LDL). A 
wide range of inflammatory cell types has been found in advanced atherosclerotic 
lesions including but not limited to macrophages/monocytes, lymphocytes, and dendritic 
cells. 41 Infiltration of these inflammatory cells occurs primarily in the neointima, aiding in 
the inward rather than outward remodeling in atherosclerosis. Glagov et al. were the first 
to describe compensatory outward remodeling that partially compensated for intimal 
expansion. 42 A recent study proposed that IL-1 is an important factor that enhances 
outward remodeling, protecting the artery from stenosis. 43 Inhibition of the IL-1 pathway 
actually enhanced macrophage infiltration and caused further narrowing of the arterial 
lumen. MMPs assist in the outward remodeling process and are implicated as a cause of 
AAA formation, but in atherosclerosis, MMPs are predominantly expressed in the 
atherosclerotic plaque, leading to plaque instability. 44,45 In contrast, Figure 1 
demonstrates that the inflammatory lesions in AAA tend to occur in the outer layers of 
the media and adventitia, where they may be expected to have a greater impact on 
outward remodeling. The presence of inflammatory cells and their associated cytokines 
and proteases may protect from arterial narrowing by promoting outward remodeling. 
Taken to the extreme, this inflammatory response may promote overcompensation in the 
outward remodeling process by causing aneurysm formation. 46  
 
Inflammatory cells in diabetic atherosclerosis 
 Diabetes is an important risk factor for the development of atherosclerotic 
lesions. Irreversible formation of advanced glycation end products (AGEs) is implicated 
as a cause of accelerated atherosclerosis. 47 The interaction of AGEs with mononuclear 
phagocytes induces a pro-inflammatory macrophage phenotype, resulting in production 
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of various pro-inflammatory cytokines such as TNF-α and IL-1β. 48-50 Interestingly, 
diabetes is negatively associated with AAAs. 6,51 This negative correlation may be related 
to the formation of AGEs and alterations to ECM proteins. Golledge et al. found that 
aortic tissue from patients with diabetes have decreased activities of MMP-2 and MMP-
9. 52 Modification of collagen lattices by glycation or treatment with glutaraldehyde 
reduced MMP activity. These findings suggest that modification of ECM proteins reduces 
protease activity, potentially preventing aortic wall degeneration and aneurysm 
formation.   
 
CD4+ and CD8+ T cells 
A review of the cell types involved is critical to understanding the role of 
inflammation in AAA development and progression. T cells are a heterogeneous group 
of lymphocytes with a diverse classification system and multitude of physiologic actions. 
They are initially classified based on surface expression of CD4 or CD8 molecules. CD4+ 
cells recognize antigens presented by major histocompatibility complex (MHC) Class II, 
while CD8+ cells recognize antigens presented by MHC Class I, important in cell-
mediated toxicity. 53 Most modulatory T cells express CD4 while most cytotoxic T cells 
express CD8. The CD4+ T cell has been found to be the predominant cell type in human 
aneurysm tissue. Through its profile of secreted cytokines, the CD4+ T cell indirectly 
controls matrix metabolism by recruitment of macrophages and regulation of ECM and 
protease synthesis. 
 
T cell phenotypes: Th1, Th2, Th17, and Treg 
CD4+ T cells can be further subdivided into the T helper (Th) or T effector (Teff) 
subsets: Th1, Th2, and Th17 and the regulatory subset: T regulatory (Treg) cells. Each 
subset is classified by the cytokine profile required for stimulation, their secreted 
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products, and their physiologic actions. In human disease, there is rarely polarization to 
one specific cell phenotype but an imbalance between pro-inflammatory and anti-
inflammatory CD4+ cells may enhance aneurysmal disease progression.  
 
Th1 
 The Th1 cell has been linked to many chronic auto-inflammatory disorders 
including: 54,55 rheumatoid arthritis, 56 emphysema, 57 and systemic lupus erythematosis. 
58 Th1 cells are characteristically activated by IL-12, triggering the signal transducer and 
activator of transcription 4 (STAT4) and T-bet pathway to produce IFN-γ, TNF-α, and 
TNF-β (Table 1.1). 54,55,59-63 This leads to activation of macrophages and an internal 
autoregulatory loop to potentiate Th1 development and inhibit alternate T cell 
differentiation. Through this cycle, IFN-γ activates macrophages and enhances 
inflammatory cell recruitment through augmenting cytokine, chemokine, and adhesion 
molecule expression. 60,61 Macrophages then produce additional IL-12, which promotes 
further Th1 activation. 54,60 This potentiates a cycle of matrix destruction and enhanced 
aneurysm formation. Interestingly, the best data available is conflicting regarding the 
expression of IL-12 and its downstream transcription factor STAT4. IL-12 protein levels 
are decreased in AAA tissue compared to aortic occlusive disease tissue. 60 Conversely, 
STAT4 levels are upregulated in AAA compared to non-aneurysmal control. 64 This 
apparent inconsistency may be due to different controls used for each study. The 
decrease in IL-12 from AAA patients was in comparison to patients that have severe 
atherosclerosis, whereas the STAT4 increase from AAA patients was in comparison to 
organ donors who likely had minimal disease.  
 Galle et al. found human aneurysmal tissue expressed high levels of IFN-γ but 
not IL-4, a typical Th2 marker. 29 They also identified overexpression of T-bet, the 
intracellular signaling pathway for Th1 polarization, without significant Th2 signaling.  
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Table 1.1 
Table 1.1. Th cell differentiation, function, and role in disease. 
 Th1 Th2 Th17 Treg 
Stimulating Factors IL-12 
 
IL-4 IL-23, IL-1, IL-6 IL-2, TGF-β 
Pathway STAT4, T-bet STAT6, GATA-3 RORγt, STAT3 STAT5, Foxp3 
Secreted Products IFN-γ IL-4, IL-5, IL-10,  
IL-13 
IL-17A & F IL-10 & TGF-β 
Role in Disease Macrophage 
activation,  
↑Inflammatory 
cell recruitment 
Limit macrophage 
cytotoxicity,   
↓MMPs & 
cytokines (IL-4/10),  
↑MMPs (IL-13) 
↑macrophage 
recruitment 
↓Teff proliferation, 
↓TNF-α & IFN-γ 
secretion from Teff 
and macrophages, 
remove 
autoreactive T cells 
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This suggests robust presence of the Th1 cell with minimal Th2 involvement in end 
stage human disease. Juvonen et al. found elevated serum levels of IFN-γ in humans 
with AAA, which correlated with an increased aneurysm growth rate. 36 We have 
previously demonstrated that mice deficient in CD4+ T cells had attenuated MMP 
expression and no aneurysm formation in a murine model of AAA, where replacing IFN-γ 
alone reconstituted aneurysm formation. 34 This contrasts with work done in the ApoE-/- 
model of AAA, where Rag1 deficiency had no effect on reducing aneurysm size. 65 This 
was also true for IFN-γ and its downstream transcription factor STAT1 in the ApoE-/- 
model. 66,67 These data highlight differences in the models. The CaCl2 model relies on an 
inflammatory response for aneurysm formation whereas the ApoE-/- model depends to a 
much greater extent on a combination of hemodynamics and hypercholesterolemia. 
Taken together, the animal models have failed to elucidate a clear role of lymphocytes 
and IFN-γ in AAA (Table 1.2).   
   
Th2 
 The Th2 cell, along with its cytokine profile, is largely considered anti-
inflammatory.   Interestingly, the Th2 cell can also be associated with inflammatory 
processes including IgE-mediated antibody responses, allergy, and asthma. 54,61,63 IL-4 
drives the differentiation of CD4+ T cells into the Th2 phenotype. Through the STAT6 
and GATA-3 pathway, the Th2 cell secretes IL-4, IL-5, IL-10, and IL-13 (Table 1). 54,55,60-
63 IL-4 and IL-10 limit the cytotoxic potential of macrophages and decrease expression of 
pro-inflammatory mediators and MMPs. IL-13 enhances development of anti-
inflammatory M2 macrophages but also increases MMP expression. 60,61   
 The Th2 cell profile has been implicated as a culprit in aneurysmal disease in 
both human and murine studies. 68 Schonbeck et al. found increased levels of Th2 
associated cytokines and low expression of Th1 related cytokines, particularly IFN-γ, in  
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Table 1.2. 
Table 1.2. Th cell differentiation in human and experimental AAA. 
 Th1 Th2 Th17 Treg 
Human AAA Increased23, 30 Increased54,56 
Decreased23 
Increased29,65 Decreased69 
ApoE-/- AngII model Increased60  Increased62 Increased65,66 Decreased65,70 
CaCl2 model Increased28 Undefined Undefined Undefined 
Elastase-perfusion 
model 
Undefined Undefined Increased29,65 Undefined 
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human tissue. 60 They suggested that IL-4 overexpression prevents Th1 differentiation 
and that IL-4 and IL-5 induced chemoattraction of neutrophils contributes to excessive 
elastolytic activity. Shimizu et al. showed that in allografted mice aortas, AAA 
development was more severe in IFN-γ deficient mice while mice deficient in IL-4 were 
protected from AAA. 61 Contradictory to the murine data, IL-4 has been shown to 
stimulate production of ECM proteins in human fibroblasts and suppress MMP 
expression (MMP-1 and MMP-9) in human alveolar macrophages. 69,70 Chan et al. 
suggested an alternate source for the Th2 associated cytokines; another member of the 
T cell family, the natural killer (NK) T cell. 62 NK and NKT cells produce both IL-4 and 
IFN-γ and have a profile that is neither Th1 nor Th2; referred to as Th0. Unlike most 
immune cells whose function appears to decline with age, the NK and NKT cells 
increase in number and produce greater IL-4 with advancing age. The important role of 
the Th2 cell may be specific to the murine transplant model, as other murine models 
show Th1 predominance. The conflicting data between the Th1 and Th2 profiles may 
relate to technical differences in how measurements were made, differences in animal 
models, and the late disease state at which human aneurysm samples are obtained 
(Table 1.2).   
 
Th17 
 A more recently identified distinct subclass of T helper cell, the Th17 cell, has 
generated interest with regard to its potential role in AAA. This cell type is unique from 
Th1 and Th2 cells based on both its cytokine profile and differentiation pathway. 59 The 
Th17 cell is stimulated by IL-23, IL-1, and IL-6, which primarily induce retinoic acid 
receptor–related orphan receptor γt (RORγt) and STAT3, leading to secretion of IL-17 
(Table 1.1). 55,59,63,71 IL-17 has 6 known isoforms, A through F, of which Th17 cells 
secrete IL-17A and F. IL-17A, its primary cytokine, mediates many immune and 
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inflammatory diseases and is critical for vascular superoxide production. 72 The Th17 cell 
promotes macrophage recruitment to the vascular wall while deficiency of IL-17 appears 
to reduce aortic macrophages in murine models.71,72 
 Madhur et al. found aneurysm formation in the ApoE-/- murine model to be 
unchanged when comparing control mice to IL-17 knockout mice. 72 This suggested that 
IL-17 did not have a critical role in this murine model. In contrast, Sharma et al. showed 
that IL-23 and Il-17 expression was increased in human AAA. 35 Using an elastase-
perfusion murine model, deletion of IL-17 or IL-23 attenuated aneurysm development 
and decreased pro-inflammatory cytokine production. Furthermore, mesenchymal stem 
cell treatment, at the time of aneurysm induction, decreased IL-17 production and 
reduced aortic dilation. Recently, Wei et al. showed that the T helper and IL-17 
inflammatory response was diminished by administration of digoxin in a dose dependent 
manner. 71 This was associated with a decrease in AAA incidence and increased mouse 
survival in the ApoE-/- and elastase-perfusion murine models. Digoxin was found to 
antagonize RORyt, inhibit Th17, and augment Treg cells. This growing body of evidence 
suggests an important role of the Th17 cell in promoting inflammation and enhancing 
aneurysmal disease. 
 
Treg 
 Treg cells are a unique subclass of CD4+ T cells that function to counteract the 
pro-inflammatory effects of the T effector subclasses and are important in immune 
tolerance. IL-2 and transforming growth factor (TGF)-β stimulate Treg cells, which 
produce IL-10 and TGF-β through the STAT5 and forkhead box P3 (Foxp3) pathway 
(Table 1.1). 55,63 The Treg assumes the critical function of curtailing the inflammatory 
process, limiting collateral damage, and allowing matrix repair to begin. Known functions 
of Treg cells include blocking further proliferation of Teff cells, 63,73 inhibiting the 
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inflammatory cascade by blocking TNF-α and IFN-γ secretion from effector cells and 
invading macrophages,48 and removal of autoreactive T cell clones generated in 
response to matrix degradation products.74 Because one of the most important functions 
of the Treg cells is to limit the proliferation of Teff cells, a relative increase in Teff cells 
indicates a loss of control of the inflammatory response. Yin et al. showed a reduction in 
the proportion of Treg cells in AAA patients. 75 Increasing the Treg population, by injection 
of splenic Treg cells from a donor mouse, protected ApoE-/- mice from aneurysm 
formation. 76 An imbalance in the proportion of the Treg cell population or dysfunction of 
the Treg cell has been implicated in other chronic inflammatory processes, including 
COPD, 57,77 inflammatory bowel disease, 78,79 lupus, 58,80,81 scleroderma, 82,83 and organ 
rejection. 84,85 Importantly, matrix destruction, which leads to end stage disease in each 
of these processes, appears to represent collateral damage from an uncontrolled 
inflammatory response. Normally functioning Treg cells have the potential to limit matrix 
damage by inhibiting T cell proliferation, blocking TNF-α and IFN-γ secretion, and 
removing autoreactive T cells. 
In summary, the majority of CD4+ cells are effector T cells whose specific role is 
largely confined to regulation of the acute inflammatory response as part of their central 
purpose in the adaptive immune system. With an acute insult, these cells are pivotal to 
the normal host defense. As part of this initial and aggressive response, the Teff cells 
secrete and induce the secretion of proteases allowing the inflammatory cells to migrate 
into tissues to establish contact with the injurious agent. In normal conditions, the Treg 
allows for resolution of this response once the threat has been curtailed. In chronic 
inflammatory processes such as AAA, this pro-inflammatory and proteolytic milieu is not 
adequately opposed by anti-inflammatory mechanisms. The result is significant and 
progressive destruction of the ECM.    
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Macrophage phenotypes: M1 and M2 
 Macrophages play crucial roles in the innate and adaptive immune responses 
and have been studied in various diseases since their discovery in the late 19th century 
by Élie Metchnikoff. Like other immune cells, macrophages respond to various stimuli in 
their microenvironmental milieu. These highly plastic cells play dual roles in initiation and 
resolution of inflammation. The macrophage population consists of two major 
phenotypes, M1 and M2. M1 macrophages respond to stimuli that enhance and sustain 
ongoing inflammation via production of proteolytic enzymes and pro-inflammatory 
mediators. Initial arterial injury leads to recruitment of M1 macrophages.  Normally, these 
infiltrating macrophages would later convert to M2 macrophages, promoting tissue repair 
and wound healing. This M1/M2 balance is vital to proper wound repair and resolution of 
the inflammatory response.  If the M1 phenotype continually predominates, chronic 
inflammation occurs. Conversely, if the M2 phenotype predominates, ongoing infection 
or poor wound healing may result. In certain cancers this M2 imbalance has been shown 
to be detrimental, actually leading to tumor growth. 86,87 Histologically, AAA tissue shows 
marked inflammatory cell infiltrates. Evidence suggests a chronic inflammatory milieu 
where the M1 phenotype is not adequately balanced by the M2 phenotype, consistent 
with progressive aneurysm expansion.   
 
M1 
 M1 macrophages respond to environmental stimuli and sustain ongoing 
inflammation via production of proteolytic enzymes and pro-inflammatory mediators. The 
classical M1 macrophage phenotype can be activated in vitro by pro-inflammatory 
cytokines including IFN-γ and TNF-α. IFN-γ primes the macrophages for activation but is 
inadequate alone to produce the M1 phenotype. 88 A secondary signal, such as TNF-α or 
lipopolysaccharide (LPS), is required for the activation of toll-like receptor 4 (TLR4) 
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resulting in M1 macrophage polarization. 89 This phenotypic polarization triggers 
production of various M1 markers such as inducible nitric oxide synthase (iNOS), TNF-α, 
IL-1β, and other pro-inflammatory mediators (Table 1.3). Characteristic cell surface 
markers, including those associated with antigen presentation such as CD80 and CD86, 
can further identify these cells as M1 macrophages. The M1 macrophage products may 
produce a positive feedback loop resulting in chronic inflammation and significant tissue 
damage.   
 In AAAs, examination of these M1 markers in human tissues and in experimental 
animal models has yielded noteworthy results. Many studies have focused on the 
discovery of novel biomarkers in AAA patient serum. Through these studies, researchers 
have identified some potential targets, which are associated with the M1 phenotype. 
Although human studies of macrophages in AAA have been limited to examination of 
end stage disease tissue or circulating monocytes, key findings have emerged. 
Circulating monocytes from AAA patients displayed enhanced adhesive activity to the 
endothelial cell wall and increased MMP-9 production. 90 Although these monocytes 
were not studied specifically for M1 or M2 markers, their presence suggests a systemic 
inflammatory response, which would be expected due to the presence of high levels of 
MMP-9 resulting in tissue breakdown. Hance et al. demonstrated that monocyte 
chemotaxis to AAA tissue can be directly linked to breakdown of the ECM, specifically 
via a six-peptide sequence (VGVAPG) found mainly in elastin. 91 Experimental animal 
studies have shown that blocking the presence of the VGVAPG sequence with a 
monoclonal antibody reduces monocyte/macrophage recruitment limiting further ECM 
breakdown. 92-94 These ECM breakdown products act as pro-inflammatory mediators, 
further recruiting monocytes and promoting their differentiation into M1 macrophages. 
Once initiated, the resolution of this inflammatory response is unlikely.   
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Table 1.3 
Table 1.3. Macrophage differentiation, function, and role in disease 
 M1 M2 
Stimulating Factors TNF-α, IFN-γ, LPS IL-4, IL-13, IL-10 
Pathway STAT1, AP-1, NF-κB STAT6, PPAR-γ, CREB 
Secreted Products TNF-α, IL-6, IL-1β, iNOS, 
MCP-1 
Arg1, Ym1, FIZZ1 (mouse 
only) 
CD markers CD80, CD86, CD16, CD14 CD206, CD163 
Role in Disease Pro-inflammatory, cytotoxicity, 
microbicidal activity, tumor 
suppression 
Anti-inflammatory, matrix 
remodeling, tissue repair, 
tumor suppression 
AP – activator protein, NF-κB – nuclear factor-κB, PPAR – peroxisome proliferator-
activated receptor, CREB – cAMP response element-binding protein, Arg – arginase, 
Ym1 – Chi3l3 (Chitinase 3-like-3), FIZZ – found in inflammatory zone 
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Various cell surface markers are associated with M1 macrophage polarization. 
CD14 acts as a co-receptor with TLR4, which is required for M1 polarization through the 
IFN-γ and LPS activation pathway. 95 Recent studies showed that patients with AAAs 
have increased levels of CD14+CD16+ monocytes compared to control patients, 
suggesting these monocytes may be associated with the chronic inflammatory process 
of AAA. 96 CD16, a low affinity Fc receptor for IgG antibodies involved in antibody-
dependent cytotoxicity, is also associated with an M1 macrophage polarization. 97 
Experimental aneurysm models indicated that CD14 deletion reduced inflammatory cell 
infiltration therefore reducing AAA incidence. 98 With the increase in CD markers 
associated with increased pro-inflammatory processes, it is clear that the M1 phenotype 
plays a major role in AAAs, at least in the latter stages of disease when tissue samples 
are obtained.  
 Examination of pro-inflammatory cytokines in AAAs has been more extensive 
and has led to many treatment strategies focused on their antagonism. M1 associated 
pro-inflammatory cytokines TNF-α, IL-6, IL-1β, and IFN-γ were all increased in human 
aneurysmal tissue and serum (Table 1.4). 36,37 IFN-γ is one stimulus that activates M1 
macrophage polarization, and deletion of IFN-γ in experimental mouse models inhibited 
aneurysm formation and macrophage infiltration. 34 Another M1 associated cytokine, 
TNF-α, stimulates M1 macrophage polarization resulting in further TNF-α production. 
Genetic deletion of TNF-α or antibody-mediated sequestration with Infliximab reduced 
macrophage infiltration and aneurysm formation in a murine model. 99 Similar deletion 
studies focused on M1 associated cytokines IL-6 and IL-1β have yielded comparable 
results. 100,101 Without these M1 polarizing cytokines, aneurysm formation is dramatically 
reduced and macrophage infiltration is minimized. These data are now being further 
investigated in a translational study using Canakinumab, an IL-1β neutralizing antibody,  
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Table 1.4 
Table 1.4. Macrophage differentiation in human and experimental AAA. 
 M1 M2 
Human AAA Increased30,31,90 Increased101,102 
ApoE-/- AngII model Increased92 Increased103 
CaCl2 model Increased28,93,94,95 Undefined 
Elastase-perfusion model Increased92 Undefined 
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in patients with small AAAs with a goal of inhibiting aneurysm expansion 
(NCT02007252). 102  
 
M2 
 In contrast to classically activated M1 macrophages, alternatively activated M2 
macrophages are associated with wound repair and inflammation resolution. M2 
activation is achieved by IL-4 or IL-13, both antagonizing the actions of IFN-γ. IL-4 and 
IL-13, associated with Th2 cells, bind to the IL-4 receptor and signal M2 polarization 
through STAT6. 103,104 Polarization of macrophages to an anti-inflammatory M2 
phenotype results in production of anti-inflammatory cytokines including IL-10 and TGF-
β. The M2 macrophage is identified by markers such as mannose receptor (CD206), 
arginase I, and CD163 (Table 1.3). These anti-inflammatory markers have been 
identified in tumors, where tumor-associated M2 macrophages suppress the natural 
immune response to cancer cells. 105 However, in diseases associated with chronic 
inflammation such as AAA, enhancement of the M2 response could potentially limit the 
ongoing inflammatory response.    
 A few recent studies have examined one of the most common M2-linked 
markers, CD206. CD206 regulates the levels of glycoproteins released after 
inflammatory responses, aiding in wound resolution. 106 Examination of CD206 in human 
AAA tissue has revealed contrasting results. Boytard et al. demonstrated that CD206+ 
macrophages are present in the intraluminal thrombus (ILT) but absent in the heavily 
damaged aortic adventitia. 107 Conversely, Dutertre et al. found CD206+ macrophages to 
be present in the damaged aorta, potentially signaling wound resolution. 108 An 
experimental aneurysm model using ApoE-/- mice revealed increased CD206 staining in 
the more severely affected tissue. 109 These contradictory data indicate the further need 
for M2 phenotype clarification and examination of additional M2 markers. Despite the 
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conflicting results, targeting the M1/M2 imbalance may offer an interesting therapeutic 
aim in aneurysmal disease.  
 
Neutrophils and mast cells 
 Neutrophils are quickly recruited to sites of injury and are characteristic of acute 
inflammation. 110 These cells are most commonly found in the ILT in AAAs. 111,112 While 
ILT are frequently found in human AAAs, animal models fail to recapitulate formation of 
an ILT. 113 However, examination of neutrophils in AAA has elucidated important 
findings. In an elastase-perfused model of aneurysm formation, depletion of 
polymophonuclear neutrophils reduced aortic dilation in a MMP-independent manner. 114 
Human AAA studies revealed a negative correlation of neutrophil catalase activity and 
aortic size. 115 These studies indicate a role for neutrophils in aneurysm formation that 
may depend on regulation of reactive oxygen species.  
 Mast cells are inflammatory cells associated with immediate hypersensitivity and 
chronic allergic reactions. 116 These cells have been found in human AAA tissue, 
primarily residing in the media and adventitia. 117,118 Genetic deletion of mast cells 
protects against aneurysm formation in both the elastase-perfusion and CaCl2 murine 
models of aneurysm formation. 119 MMP-2 and -9, as well as other ECM degrading 
enzymes, can be activated by mast cell secreted chymase, promoting aneurysm 
formation. 120,121 Although much of the focus on aneurysm formation has been on T cells 
and macrophages because they are the predominant inflammatory cells, interactions 
between these and other inflammatory cells also play a role in aneurysm formation.  
 
Discussion 
 AAA is a complex disease where an improper balance of T cell or macrophage 
phenotypes may worsen the disease process. This imbalance that occurs with the 
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numerous cell types involved in AAAs enhances the chronic inflammatory aspect of the 
disease. CD4+ T cells display many different phenotypes, most of which have been 
found in AAA tissue. Studies targeting the switch of T cells from a pro-inflammatory 
phenotype to an anti-inflammatory phenotype, such as upregulation of Treg cells, create 
exciting new strategies for targeting AAA progression. Macrophage phenotype 
polarization is a promising new field that may prove beneficial in identifying key 
regulators of chronic inflammation in AAA. Whether macrophages in AAA tissue exhibit a 
stronger M1 or M2 phenotype and altering the M1/M2 balance are being explored. 
Understanding and addressing the imbalances in the immune system associated with 
AAA offer new and exciting translational strategies.   
It is difficult to determine the cause of AAA in humans because of the chronicity 
of the disease and the problem of obtaining specimens at different stages of the disease 
Therefore, investigators have attempted to make use of animal models with similarities 
to the human disease. Validations of these animal models must be performed by 
correlating these studies with human tissueobtained from patients with end stage 
disease. Correlating data obtained from murine models to human AAA tissue has yet to 
yield useful therapeutic inflammation thus far. Therefore, development of humanized 
animal models may help to alleviate some of the differences seen in the human and 
mouse disease process. Opportunities to obtain human AAA tissue are becoming more 
limited due to the transition from open to endovascular aneurysm repair. Clinical trials 
must develop protocols to examine as many parameters of the disease as possible, 
including serially obtaining precise imaging and circulating biomarkers. By correlating 
biomarkers with changes in aneurysm shape and size, it may be possible to develop a 
greater understanding of which bioactive molecules and cell types promote aneurysm 
growth. 
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CHAPTER 2 
 
 
 
Genetic differences in MMP levels influence AAA susceptibility  
 
 
The following is a modified version of an article published in Atherosclerosis 2015 Dec; 
243(2):621-9. This work was coauthored by Melissa K. Suh, Shijia Zhao, Trevor 
Meisinger, Linxia Gu, Vicki J. Swier, Devendra K. Agrawal, Timothy C. Greiner, Jeffrey 
S. Carson, B. Timothy Baxter, Wanfen Xiong, and myself.   
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Introduction  
Abundant evidence has demonstrated the profound influence of genetic 
background on cardiovascular phenotypes.	  122-­‐125 Although a single gene mutation has 
not been found in association with most AAAs, a positive family history of AAA in a first 
degree relative is known to increase the risk of aortic aneurysm by up to a factor of ten.	  
126 Attempts to define the genetic component(s) underlying AAA have used a variety of 
strategies, including both linkage analysis and candidate gene approaches;	   127 
nonetheless, a consensus on the patterns of inheritance or specific linkages associated 
with AAA has yet to emerge.  
A variety of different mouse strains have been used to assess aortic aneurysms.	  
109,128-­‐131 The most widely used parent strains for the production of mutants in aneurysm 
research are C57Bl/6 and 129/SvEv mice. 25,26,132 In contrast to AAA, thoracic aortic 
aneurysms are associated with a number of known genetic mutations. Marfan syndrome 
(MFS) is caused by fibrillin-1 gene mutations that are responsible for thoracic aneurysm 
development. 133 Studies of animal models of MFS have shown that genetic background-
related variations, C57Bl/6 or 129/SvEv, affect aneurysm formation, rupture, and lifespan 
of mice. 132,134 The 129/SvEv genetic background is associated with more rapid 
aneurysm progression in MFS mice when compared to the C57Bl/6 background.	  132 As 
in AAA, higher MMP-2 expression in the aorta of Marfan syndrome mice plays an 
important role in aneurysm formation. 133 Therefore, the variance of thoracic aneurysm 
susceptibility in MFS could also be informative regarding the underlying genetic 
susceptibility to AAA. In reviewing our previous studies, we noted that 129/SvEv mice 
also developed larger AAAs compared to C57Bl/6 mice in response to CaCl2-aneurysm 
induction.	  25 Based on these observations, we hypothesized that the difference seen in 
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aneurysm susceptibility between the two genetic backgrounds is related to intrinsic 
differences in smooth muscle cell MMP-2 or macrophage MMP-9 expression. 
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Methods 
Animal aneurysm model. All procedures and animal studies were approved by the 
University of Nebraska Medical Center IACUC. The experimental groups consisted of 24 
eight weeks-old male C57Bl/6 mice (The Jackson Laboratory, Bar Harbor, Maine) and 
20 eight weeks-old male 129/SvEv mice (Taconic, Germantown, New York). Mice were 
anesthetized and underwent laparotomy. The abdominal aorta between the renal 
arteries and bifurcation of the iliac arteries was isolated from the surrounding 
retroperitoneal structures. The diameter of the aorta was measured using a Leica 
Application System (Leica Microsystems Inc, Buffalo Grove, IL).  After baseline 
measurements, 0.25 M CaCl2 was applied to the aorta with care taken to avoid 
surrounding tissue. After 15 minutes the aorta was rinsed with 0.9 % sterile saline, the 
laparotomy incision was closed, and mice were returned to their cages after recovery. 
Six weeks later the mice underwent repeat laparotomy, dissection, and measurement of 
the aorta. Aortic diameter was measured at the point of maximal dilatation. The aorta 
tissue was collected for zymographic and Western blot analyses. For histological 
studies, the aorta was perfusion-fixed with 10% neutral buffered formalin. NaCl (0.9%) 
was substituted for CaCl2 in sham controls. 
 
Isolation and infusion of myelogeous cells. To evaluate the role of the myelogenous 
cells on aneurysm susceptibility, 6 week-old C57Bl/6 or 129/SvEv mice were irradiated 
(1200 rads) and transplanted with bone marrow from 129/SvEv (designated as 
C57bkg/SvEvbm mice) or C57Bl/6 mice (SvEvbkg/C57bm mice), respectively. As controls, 
we also transplanted bone marrow from C57Bl/6 or 129/SvEv mice into the irradiated, 
same back ground mice, C57Bl/6 (designated as C57bkg/C57bm) or 129/SvEv ( 
SvEvbkg/SvEvbm), respectively. We have previously demonstrated that this radiation 
protocol results in bone marrow ablation and is fatal without rescue by bone marrow 
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transplantation.	   135 Bone marrow cell suspensions were prepared from the femurs of 
C57Bl/6 or 129/SvEv mice, and 5 × 106 cells were infused via the lateral tail veins. 
Aneurysm induction followed 1 week after bone marrow transplantation. 
Western blot analysis and gelatin zymography. Aortic proteins were extracted as 
previously described. 133 The protein concentration of aortic tissues was standardized 
with a Bio-Rad protein assay. Equal amounts (10 µg) of aortic extracts were loaded 
under reducing conditions onto a 10% SDS-polyacrylamide gel and transferred to a 
polyvinylidene difluoride (PVDF) membrane (Amersham Biosciences, Piscataway, NJ). 
The membranes were then incubated with rabbit anti-tropoelastin antibody (Elastin 
Products Company, Owensville, MO) or rabbit anti-collagen1a antibody (Cell Signaling, 
Danvers, MA). The bound primary antibody was detected with HRP-linked anti-rabbit IgG 
(Cell Signaling). Immunoreactive bands were visualized by autoradiography using ECL 
(Amersham Biosciences). Gelatin zymography for aortic tissue extracts was performed 
as described previously by Longo et al., with 0.8% gelatin in a 10% SDS-polyacrylamide 
gel.7 (Longo 2002) The molecular sizes were determined using protein standards from 
Fermentas (Glen Burnie, MD). The intensity of each band was quantified by 
densitometry (Amersham Biosciences). 
Microscopy. 1)Verhoeff-Van Gieson (VVG) connective tissue staining: After perfusion-
fixation with 10% neutral-buffered formalin, mouse abdominal aortic tissues were 
embedded in paraffin and cut into 4 µm sections. The slides were stained with Verhoeff’s 
solution, ferric chloride, sodium thiosulfate, and Van Gieson’s solution (Poly Scientific, 
Bay Shore, NY). Each staining cycle alternated between fixing and washing procedures. 
The slides were examined and photographed using light microscopy (Nikon). 2) 
Quantification of Elastin Disruption: slides of both CaCl2 treated C57Bl/6 and 129/SvEv 
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mice were examined under low power magnification. A semi-quantitative analysis was 
used to estimate the percentage of the total circumference that demonstrated elastin 
disruption. The analysis was performed by an observer blinded to mouse background. 3) 
Immunohistochemistry: Tissue sections on the slides were deparaffinized in xylene, 
rehydrated in ethanol, and rinsed in double-distilled water. The sections were incubated 
with a monoclonal rat anti-mouse Mac3 antibody (PharMingen, San Diego, CA) diluted 
1:500 for 30 minutes at 37oC. The sections were then briefly washed in citrate solution 
and subsequently incubated with the secondary antibody, which is a mouse-absorbed, 
biotin-conjugated rabbit anti-rat IgG. Macrophage staining was examined using light 
microscopy. Sections incubated with secondary antibody only showed no positive 
staining. Three samples in each mouse strain were stained and evaluated.  
 
Elastic modulus measurement. Quasi-static nanoindentation tests were performed on 
mouse aortas using a commercial TriboScope nanoindenter with a light microscope 
mounted (Hysitron, Minneapolis, MN). A nonporous conospherical fluid cell probe (TI-
0077) with a radius of curvature of R = 100 µm was chosen. A custom-built sample 
holder was used to hold sample and ensure its hydration during indentation test. The 
optical images obtained from the microscope will guide the movementt of the indenter 
and allow accurate control on the indentation positions.  
A trapezoidal load-hold-unload profile, which was composed of a linear loading 
portion of 2 seconds, a dwell portion of 20 seconds at a predetermined peak load and a 
linear unloading portion of 2 seconds, was used for each indentation. All samples were 
tested at peak load of 5 µN during the dwell period. In total, 16 indentations in a 4✕4 grid 
were conducted on each sample. The time interval between two indentations was 120 
seconds. The distance between two indentation points was 200µm. After indentations, 
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the force-displacement data were collected. The elastic moduli of the specimens were 
obtained by fitting the force-displacement data to the Oliver-Pharr model. 
 
Elastase activity assay. Elastase activity in the aortic extract (100 µg) from NaCl- and 
CaCl2-treated C57Bl/6 and 129/SvEv mice were measured using an elastase assay kit 
(AnaSpec, Fremont, CA) with and without 10 mM EDTA according to manufacturer 
instructions. Neutrophil elastase gene expression in the aortic tissue of NaCl- and CaCl2-
treated C57Bl/6 and 129/SvEv mice were examined by RT-PCR as described 
previously.24 
 
Statistical analysis. Measurements of aortic diameter, elastin levels, and elastic moduli 
were expressed as mean value ± S.D. ANOVA was used to compare aortic diameters. 
Student’s t test was used to compare protein expression, MMP activity, and elastic 
moduli in different groups. Statistical significance was accepted at the P < .05 levels.  
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Results 
Aneurysm size and histology. To test the hypothesis that genetic influences contribute 
to susceptibility of aneurysm formation, 129/SvEv and C57Bl/6 mice were subjected to 
CaCl2-aneurysm induction. Six weeks after periaortic application of CaCl2, 129/SvEv 
mice showed a larger increase in abdominal aortic diameter compared to C57Bl/6 mice 
(Fig. 1a, b-e and Table 1). The initial aortic diameter between two strains was not 
significantly different. At baseline, VVG staining of aortic sections from C57Bl/6 and 
129/SvEv mice showed no difference (Fig. 1f, g, j, k) while both showed disruption and 
fragmentation of medial elastic lamellae after aneurysm induction (Fig. 1h, i, l, m). 
However, aortic elastic lamellae degradation appeared to be more severe in 129/SvEv 
mice (Fig. 1i & m) compared to C57Bl/6 mice (Fig. 1h & l).  These observations are 
consistent with the larger aneurysms that develop in the 129/SvEv mice. 
 
Aortic elastic moduli. The elastic lamella, which is comprised of elastic fibers, 
collagens, proteoglycans, and glycosaminoglycans, determines the biomechanical 
properties of the aorta. To test the hypothesis that baseline aortic mechanical properties 
of C57Bl/6 mice differed from 129/SvEv mice, quasi-static nanoindentation tests were 
performed on the aortas isolated from the two strains of mice. The elastic moduli of the 
specimens were obtained by fitting the force-displacement data to the Oliver-Pharr 
model. The elastic moduli of C57Bl/6 mice were significantly less than that of the 
129/SvEv mice (Fig. 2). Thus, the aortic wall in 129/SvEv mice was stiffer or less 
compliant than in the C57Bl/6 mice. 
 
Aortic tropoelastin content. Matrix synthesis is known to accompany the matrix 
degradation seen in AAA. Production of tropoelastin, the precursor molecule that 
becomes incorporated into mature elastin fibers, in the aneurysmal aortas was examined   
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Figure 1. Aortic changes after NaCl and CaCl2 treatment in C57Bl/6 and 129/SvEv 
mice.  Aortic diameters were measured before NaCl or CaCl2 incubation and at sacrifice.  
Aortic diameter increases are shown in the bar graph (a).   Bars represent the mean +/- 
SD of at least 6 mice per group.  The diameter in the CaCl2-treated groups was 
increased significantly at sacrifice in both C57Bl/6 and 129/SvEv mice compared to NaCl 
treated mice (* P < .01).  The aortic dilatation in CaCl2-treated 129/SvEv mice was 
significantly greater compared to CaCl2-treated C57Bl/6 mice (# P < .05). Photographs 
(b-e) show the mouse aortas in C57Bl/6 and 129/SvEv mice with the dotted line 
indicating the outer border of the aortas before (b, c) and after (d, e) CaCl2 aneurysm 
induction, respectively, (n = 6-10/group). VVG staining for elastic fibers (f-m). Aortic 
lamellae disruption (10✕ magnification) (h, i) and elastic fiber fragmentation (40✕ 
magnification) (l, m) were more severe in 129/SvEv (i. m) than in C57Bl/6 (h, l) mice (n = 
3-5/group). n, percentage of aortic circumference showing elastin disruption in CaCl2-
treated C57Bl/6 and 129/SvEv mice (n = 3 aortas/group). 
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mice (* P < .01).  The aortic dilatation in CaCl2-treated 129/SvEv mice was significantly 
greater compared to CaCl2-treated C57Bl/6 mice (# P < .05). Photographs (b-e) show the 
mouse aortas in C57Bl/6 and 129/SvEv mice with the dotted line indicating the outer 
border of the aortas before (b, c) and after (d, e) CaCl2 aneurysm induction, respectively, 
(n = 6-10/group). VVG staining for elastic fibers (f-m). Aortic lamellae disruption (10✕ 
magnification) (h, i) and elastic fiber fragmentation (40✕ magnification) (l, m) were 
more severe in 129/SvEv (i. m) than in C57Bl/6 (h, l) mice (n = 3-5/group). n, 
percentage of aortic circumference showing elastin disruption in CaCl2-treated C57Bl/6 
and 129/SvEv mice (n = 3 aortas/group). 
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Table 1.  
 
Table1. Changes in aortic diameter in C57Bl/6 and 129/SvEv mice after  
 
treatment of NaCl and CaCl2 
 C57Bl/6 129/SvEv 
Treatment NaCl CaCl2 NaCl CaCl2 
Number 8 16 6 12 
Pre-treatment (µm) 520 ± 14 507 ± 7 544 ± 15 550 ± 17 
Post-treatment (µm) 562 ± 17 797 ± 30 * 628 ± 18 1067 ± 67 *# 
AAA development 
(%) 
0 56 0 83 
Percent Increase (%) 8.3 57.8 15.9 96.3 
Aortic diameters were measured before NaCl or CaCl2 incubation (Pre) and at sacrifice 
(Post). Measurements of aortic diameter were expressed as mean ± SE. The percent of 
increase was represented as a percent compared with pre-treatment. The development 
of aneurysm was defined as at least a 50% increase relative to original aortic diameter. * 
P <.01, Student’s t test, compared to pre-treatment; # P < .05 compared to CaCl2-treated 
C57Bl/6.  
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Figure 2. Elastic modulus of aortic tissues from C57Bl/6 and 129/SvEv mice. Prior 
to aneurysm induction, quasi-static nanoindentation tests were performed  on the aortas 
and the elastic modulus was determined (n = 3 per group, * P < .05).   
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Figure 2. Elastic modulus of aortic tissues from C57Bl/6 and 129/SvEv mice Prior to 
aneurysm induction, quasi-static nanoindentation tests were performed  on the aortas and 
the elastic modulus was determined (n = 3 per group, * P < .05).   
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by Western blot analysis. At baseline, there was no different in tropoelastin production 
between two strains (Fig. 3a). The tropoelastin levels in CaCl2-treated aortas of 
129/SvEv mice were decreased by one third compared to CaCl2-treated aortas of 
C57Bl/6 mice (Fig. 3b). The procollagen 1α levels in the aortas were also examined by 
Western blot analysis. There was no difference in procollagen 1α content between the 
two strains of mice (data not shown). These data suggest that the 129/SvEv mice may 
be less able to repair elastin once it has been disrupted.  
 
Aortic MMP-2 and MMP-9 expression.  MMP-2 and MMP-9 are essential for the 
connective tissue degradation in the aortic wall leading to AAA. 25 Because the greater 
level of elastin degradation in the 129/SvEv mice suggests higher levels of MMP activity, 
we determined if the aortas from C57Bl/6 and 129/SvEv mice expressed different levels 
of MMP-2 and MMP-9 at baseline and after aneurysm induction. Aortic protein was 
analyzed by gelatin zymography. As shown in Figure 4a, latent MMP-2 expression in 
untreated 129/SvEv mice was significantly higher than in untreated C57Bl/6 mice. 
Furthermore, after aneurysm induction, active forms of MMP-2 and MMP-9 were higher 
in the aortas of 129/SvEv mice (Fig. 4b). These results demonstrated that 129/SvEv 
mice express higher levels of pro-MMP-2 intrinsically. Additionally, after aortic injury, 
there is greater activation of MMP-2 and MMP-9 in 129/SvEv mice.  
Increased MMP-9 expression in aortic tissues after aneurysm induction may 
indicate higher levels of MMP-9 expression from macrophages or increased 
macrophage infiltration into the aortic tissue in 129/SvEv mice compared to C57Bl/6 in 
response to CaCl2 treatment. Therefore, aortic tissues were examined for the presence 
of Mac3-positive macrophages. The images obtained suggested greater macrophage 
infiltration in the 129/SvEv mice aortas compared to C57Bl/6 mice (Fig. 4c). These  
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Figure 3. Aortic tropoelastin content. Western blot analysis was used to determine 
tropoelastin content from C57Bl/6 and 129/SvEv mice before (a) and after (b) AAA 
induction. Relative levels of tropoelastin content in mouse aortas were quantified as 
shown in bar graphs (* P < .05 compared to CaCl2-treated C57Bl/6 mice) (n = 5-
7/group). 
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Figure 3. Aortic tropoelastin content Western blot analysis was used to determine 
tropoelastin content from C57Bl/6 and 129/SvEv mice before (a) and after (b) AAA 
induction. Relative levels of tropoelastin content in mouse aortas were quantified as shown 
in bar graphs (* P < .05 compared to CaCl2-treated C57Bl/6 mice) (n = 5-7/group). 
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Figure 4. Aortic MMP-2 and MMP-9 expression. Gelatin zymography analysis of MMP 
activities expressed in the aortas of C57Bl/6 and 129/SvEv mice, a)  Untreated controls; 
b) CaCl2-treated mice.  Representative zymogram gels are shown in left panels.  
Relative levels of pro-MMP-9, MMP-9, pro-MMP-2, MMP-2 in mouse aortas were 
quantified and data shown in the bar graphs (* P < .05). c) Representative 
immunoperoxidase staining for macrophages of aneurysmal aortic tissues from C57Bl/6 
and 129/SvEv mice.  Mac3-positive cells are indicated by arrows. Macrophages in aortic 
tissue were evaluated and scored with values from 0-3 as previously described (7).  Zero 
indicates that there were no Mac3-positive cells, 3 indicated many Mac3-positive cells in 
a limited area, and 1 and 2 were used to classify intermediate grades of Mac3 positive 
cells (n = 3/group).  
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Figure 4. Aortic MMP-2 and MMP-9 expression Gelatin zymography analysis of MMP 
activities expressed in the aortas of C57Bl/6 and 129/SvEv mice, a)  Untreated controls; b) 
CaCl2-treated mice.  Representative zymogram gels are shown in left panels.  Relative levels of 
pro-MMP-9, MMP-9, pro-MMP-2, MMP-2 in mouse aortas were quantified and data shown in 
the bar graphs (* P < .05). c) Representative immunoperoxidase staining for macrophages of 
aneurysmal aortic tissues from C57Bl/6 and 129/SvEv mice.  Mac3-positive cells are indicated 
by arrows. Macrophages in aortic tissue were evaluated and scored with values from 0-3 as 
previously described (7).  Zero indicates that there were no Mac3-positive cells, 3 indicated 
many Mac3-positive cells in a limited area, and 1 and 2 were used to classify intermediate grades 
of Mac3 positive cells (n = 3/group).  
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Table 2 
Table 2. The concentration of macrophages in the CaCl2-treated aorta of 129/SvEv and 
C57Bl/6 mice 
Mouse Strain Macrophages 
129/SvEv 2.3 ± 0.6* 
C57Bl/6 1.0 ± 0.5 
Macrophages in aorta were evaluated and scored with values from 0 to 3. Zero means 
no Mac3+ cells and 3 meanys many cells in a limited area, the values of 1 and 2 are 
used to classify intermediate grades of infiltration. The values reflect the mean ± SD. * P 
= 0.0390, Student’s t-test. n = 3. 
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results suggest intrinsic differences in mesenchymal cell MMP-2 levels and also 
differences in response to injury.  
 
Aortic elastase activity.  In addition to MMP-2 and -9, other elastases could be 
responsible for the elastin degradation in AAA.  We measured elastase activity in the 
aortic tissue from C57Bl/6 and 129/SvEv mice. Elastolytic activity was similar between 
NaCl-treated C57Bl/6 and 129/SvEv mice (Fig. 5a). However, elastase activity in CaCl2-
treated 129/SvEv and C57Bl/6 mice was significantly higher than NaCl-treated 129/SvEv 
or C57Bl/6, respectively (Fig. 5a). Furthermore, compared to CaCl2-treated C57Bl/6 
mice, elastolytic activity in CaCl2-treated 129/SvEv was higher (Fig. 5a).  Neutrophils 
play an important role in aneurysm formation. 114,136 We also tested neutrophil elastase 
gene expression using RT-PCR.  We found that there were no significant differences 
between C57Bl/6 and 129/SvEv mice at baseline or in aneurysmal aortic tissue (Fig. 5b 
&c). In order to determine the contribution of MMPs, EDTA was used to block MMP 
activity prior to measuring total elastolytic activity (Fig. 5a). These data demonstrated 
that the majority of enhanced activity was due to increased elastin degradation by 
MMPs.   
 
Role of myelogenous cells in AAA susceptibility. The known role of inflammatory 
cells in AAA and differences in the levels of active MMP-9 in the C57Bl/6 and the 
129/SvEv mice suggested that there could be intrinsic differences in the myelogenous 
cells. In order to investigate this, C57Bl/6-derived bone marrow cells were infused into 
irradiated 129/SvEv (SvEvbkg/C57bm) mice and 129/SvEv-derived bone marrow cells 
were infused into irradiated C57Bl/6 (C57bkg/SvEvbm) mice. As controls, we also 
transplanted bone marrow from C57Bl/6 or 129/SvEv mice into the irradiated, same back 
ground mice, C57Bl/6 (C57bkg/C57bm) or 129/SvEv ( SvEvbkg/SvEvbm), respectively. The  
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Figure 5. Aortic elastase activity and neutrophil elastase expression  a) Elastase 
activity in aortic tissue extract from C57Bl/6 and 129/SvEv mice was measured, (* P < 
.05 compared to NaCl-treated control, # P < .05 compared to CaCl2-treated C57Bl/6 
mice) (n = 3/group). EDTA was used to block MMP activity.  b) The neutrophil elastase 
expression in the aortas of C57Bl/6 and 129/SvEv mice was examined by RT-PCR; 
untreated controls (left panel) and CaCl2-treated mice (right panel). c) The levels of 
neutrophil elastase mRNA relative to GAPDH in the aorta were quantified; data shown in 
the bar graphs (n = 3/group).  
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Figure 5. Aortic elastase activity and neutrophil elastase expression  a) Elastase 
activity in aortic tissue extract from C57Bl/6 and 129/SvEv mice was measured, (* P 
< .05 compared to NaCl-treated control, # P < .05 compared to CaCl2-treated C57Bl/6 
mice) (n = 3/group). EDTA was used to block MMP activity.  b) The neutrophil elastase 
expression in the aortas of C57Bl/6 and 129/SvEv mice was examined by RT-PCR; 
untreated controls (left panel) and CaCl2-treated mice (right panel). c) The levels of 
neutrophil elastase mRNA relative to GAPDH in the aorta were quantified; data shown 
in the bar graphs (n = 3/group).  
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chimeric mice were subjected to CaCl2-aneurysm induction. Six weeks after aneurysm 
induction, SvEvbkg/C57bm developed larger aneurysms than the C57bkg/SvEvbm (Fig. 6a). 
Aortic diameter in the SvEvbkg/C57bm increased by 85% ± 4, while the C57bkg/SvEvbm 
increased by 56% ± 6 (Table 3). The aortic diameter changes in C57bkg/C57bm and 
SvEvbkg/SvEvbm were similar to C57bkg/SvEvbm and SvEvbkg/C57bm, respectively.  
Furthermore, the disruption of the elastic lamellae of the aortic wall of CaCl2-treated 
C57bkg/SvEvbm was less severe than the SvEvbkg/C57bm chimeric mice (Fig. 6b). Aortic 
MMP-2 and MMP-9 levels in C57bkg/SvEvbm mice were lower than in SvEvbkg/C57bm mice 
while it is similar between C57bkg/C57bm and C57bkg/SvEvbm and between SvEvbkg/SvEvbm 
and SvEvbkg/C57bm(Fig. 6c). The changes in aortic diameter in the chimeric mice were 
very similar in magnitude to the differences noted when the background strains were 
compared. These data do not support the concept that differences in the white cell 
compartments account for differences in aneurysm susceptibility.  
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Figure 6. The role of myelogenous cells in AAA susceptibility.  The chimeric mice, 
C57bkg/C57bm, SvEvbkg/SvEvbm, C57bkg/SvEvbm and SvEvbkg/C57bm, were subjected to 
CaCl2 aneurysm induction.  Aortic diameter changes were shown in the bar graph (a) (* 
P < 0.01 compared to NaCl control; # P < 0.05 C57bkg/SvEvbm vs. SvEvbkg/C57bm and 
C57bkg/C57bm vs. SvEvbkg/SvEvbm after CaCl2 treatment). Bars represent the mean ± SD 
of 6 mice per group. Representative VVG staining of elastic fibers after aneurysm 
induction (b). Gelatin zymography of aortic MMP-2 and -9 levels in CaCl2-treated  
C57bkg/C57bm (lane 1), C57bkg/SvEvbm (lane 2), SvEvbkg/SvEvbm (lane 3), and 
SvEvbkg/C57bm (lane 4) (c). 
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Figure 6. The role of myelogenous cells in AAA susceptibility  The chimeric 
mice, C57bkg/C57bm, SvEvbkg/SvEvbm, C57bkg/SvEvbm and SvEvbkg/C57bm, were 
subjected to CaCl2 aneurysm induction.  Aortic diameter changes were shown 
in the bar graph (a) (* P < 0.01 compared to NaCl control; # P < 0.05 C57bkg/
SvEvbm vs. SvEvbkg/C57bm and C57bkg/C57bm vs. SvEvbkg/SvEvbm after CaCl2 
treatment). Bars represent the mean ± SD of 6 mice per group. Representative 
VVG staining of elastic fibers after aneurysm induction (b). Gelatin 
zymography of aortic MMP-2 and -9 levels in CaCl2-treated  C57bkg/C57bm 
(lane 1), C57bkg/SvEvbm (lane 2), SvEvbkg/SvEvbm (lane 3), and SvEvbkg/C57bm 
(lane 4) (c). 
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Table 3 Changes in aortic diameter in chimeric mice after treatment of NaCl and CaCl2 
 
 C57bkg/SvEvbm SvEvbkg/C57bm C57bkg/C57bm SvEvbkg/SvEvbm 
Treatment NaCl CaCl2 NaCl CaCl2 CaCl2 CaCl2 
Number 5 5 5 5 4 5 
Pre-Treatment 
(µm) 505 ± 11 534 ± 12 509 ± 7 510 ± 28 502 ± 20 517 ± 23 
Post-
Treatment 
(µm) 
540 ± 21 837 ± 48* 531 ± 6 945 ± 71*,# 779 ± 48 960 ±77 Ɨ 
AAA 
development 
(%) 
0 60 0 100 50 100 
Percent 
increase (%) 7 57 4 85 55 86 
Aortic diameters were measured before NaCl (or CaCl2) incubation (Pre) and at sacrifice 
(Post).  Measurements of aortic diameter were expressed as mean ± SD.  The percent 
of increase was represented as a percent compared with pre-treatment.  The 
development of aneurysm was defined as at least 50% increase relative to original 
diameter of aortic diameter.  * p < .01, student's t test, compared to pre-treatment; # p 
<.05 compared to CaCl2-treated C57bkg/SvEvbm; Ɨ p < .05 compared to CaCl2-treated 
C57bkg/C57bm. 
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Discussion 
The majority of genomic studies used to identify susceptibility pathways involved 
in disease pathologies have been performed in the mouse. 137-139 The mouse provides a 
suitable model for the study of human genetics because more than 95% of the genome 
is identical. The mouse genome is easy to manipulate allowing diseases to be modeled 
in transgenic animals once the target genes have been determined.  Mice are also easy 
to breed with a short generation time and a short lifespan allowing direct study of 
disease development. Abundant evidence, however, demonstrates the profound 
influence of genetic background on the course and severity of many diseases.	   140-­‐142 
Strain variability has been shown to influence aneurysm formation, progression, and 
even lifespan in MFS mouse models. Lima et al. demonstrated the effect of genetic 
background on the severity of the MFS phenotype by backcrossing the mg∆ allele, in 
which fibrillin-1 expression is reduced to 10% of normal levels, in 129/SvEv and C57Bl/6 
mouse strains. 132 The 129/SvEv background was more susceptible to aneurysm 
formation and earlier aortic rupture. Increased susceptibility to aneurysm formation in the 
129/SvEv background when compared to the C57Bl/6 background was also present in 
the least severe model of MFS (Fbn1C1039G/+; 50% normal fibrillin-1 expression levels). 
Clearly, the genetic differences between the two strains are relevant to thoracic aortic 
aneurysm pathogenesis. To determine whether the development of AAA is dependent 
on mouse genetic background, we induced aneurysms in two widely used mouse 
strains, C57Bl/6 and 129/SvEv. Mice from both genetic backgrounds displayed 
increased aortic diameters and developed aneurysms in response to CaCl2 induction, 
but the aneurysms formed in 129/SvEv mice were significantly larger compared to 
C57Bl/6 mice. Compared to our previous study, 25 the difference in CaCl2-treated aortic 
diameter between two strains was bigger in the present study. In previous study, the 
aneurysms in the two strains were not induced concurrently.  In the present study, the 
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aneurysms in two strains were induced simultaneously with one operator.  We believe 
this better represents the differences between the two strains. In NaCl-treated controls of 
129/SvEv mice, the average increase in aortic diameter was larger than previous 
reported. 25 In the present study, we have used a camera having higher resolution to 
define the aortic borders. We believe this primarily reflects growth of the aorta between 7 
to 14 weeks. Consistent with these differences in aneurysm size, aortic elastic lamellar 
disruption and degradation in 129/SvEv mice were more severe compared to C57Bl/6 
mice. Age and gender are also important factors in aneurysm development in patients 
with AAA. Mice of the same age and gender were used to exclude these as possible 
confounding factors.  
Our current results, based on determination of the elastic modulus, demonstrate 
that the abdominal aortas of 129/SvEv mice were stiffer at baseline than those of 
C57Bl/6 mice. There is indirect evidence that patients with AAAs may have a systemic 
increase in arterial stiffness. Dijk et al. have shown that the carotid artery is stiffer in AAA 
patients compared to control patients without AAA. 143 In order to determine if the 
differences in mechanical properties were related to intrinsic differences in gene 
expression, we examined aortic elastin and collagen precursor levels prior to aneurysm 
induction. C57Bl/6 and 129/SvEv mice express similar levels of tropoelastin and 
procollagen (data not shown). There is evidence that the elasticity of arterial wall may 
impact susceptibility to arterial diseases. Studies have shown that aortic elastin 
haploinsufficiency leads to high blood pressure and progressive aortic valve 
malformation. 144,145 We did not measure tail cuff blood pressure in the current study but 
other studies have demonstrated that 129/SvEv mice have higher basal blood pressure 
than C57Bl/6 mice and 129/SvEv mice are more likely to develop hypertension and renal 
damage than C57Bl/6 mice in response to deoxycorticosterone acetate. 146,147 These 
results could occur because of baseline differences in mechanical properties or be the 
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result of differences in response to exogenous stimuli. Currently, the association 
between hypertension and AAA remains unclear. It has been reported that in 
angiotensin II (Ang II) infused apoE null mice, AAA formation is independent of blood 
pressure elevation. 148-150 We have previously demonstrated that there is an ongoing 
repair mechanism in patients with AAA as evidenced by high levels of collagen gene 
expression. 151 Six weeks after CaCl2-induction, tropoelastin levels in 129/SvEv mice 
were significantly lower than C57Bl/6 mice. Procollagen levels did not differ between the 
two strains after aneurysm induction (data not shown). Aneurysm susceptibility may be 
related to baseline differences in tissue properties. This difference would be exacerbated 
in the 129/SvEv because of the reduced ability to produce equivalent amounts of 
tropoelastin as is produced by C57Bl/6.  
Matrix metalloproteinases, especially MMP-2 and -9, play important roles in 
aneurysm formation. Interestingly, 129/SvEv mice intrinsically produce higher amounts 
of latent MMP-2 in the aorta compared to C57Bl/6 mice. This results in higher levels of 
active MMP-2 in 129/SvEv after CaCl2-treatment compared to C57Bl/6. MMP-2 is 
primarily a product of resident aortic smooth muscle cells and fibroblasts. Initial 
degradation of elastin by MMP-2 may produce elastin fragments, which are known to 
induce monocyte chemotaxis. 92,152 This may account for the increased macrophage 
infiltrates seen in the aortas of 129/SvEv mice compared to C57Bl/6 mice. Baseline 
levels of active and latent MMP-9 were similar between the two mouse strains. This is 
not unexpected since macrophages are the main source of MMP-9 in aneurysm tissue 
but are not present in normal aortic tissue. 153 Levels of both latent and active MMP-9 
were higher in 129/SvEv aortas than in C57Bl/6 aortas in response to CaCl2-treatment. 
In addition to MMP-2 and -9, other proteases such as MMP-12, MMP-7, MT1-MMP, 
neutrophil elastase, and cysteine proteases may contribute to elastin degradation and 
aneurysm formation. 114,135,154-156 We tested neutrophil elastase expression in the mouse 
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aorta and found no difference between the two mouse strains (Fig. 5b). Using EDTA to 
block MMP activity, it is evident that the majority of the increased elastolytic activity is 
due to MMPs. These data suggest three possible mechanisms for the increased 
aneurysm susceptibility in 129/SvEv. First, the larger reservoir of latent MMP-2 could 
result in more elastin fragmentation with resultant recruitment of inflammatory cells to the 
aorta. Second, the differences in aneurysm sizes could be related to inherent differences 
in tissue mechanical properties. Finally, the myelogenous cells of the 129/SvEv may 
produce a more vigorous response to injury, greater elastin degradation, and aortic 
expansion.  
It is known that inflammatory infiltrates play a pivotal role in aneurysm formation. 
21,24,34,157 We investigated whether the myelogenous cell differences between the two 
strains of mice contribute to aneurysm susceptibility. Two chimeric mice were created, 
C57bkg/SvEvbm mice, hematopoietic tissue ablated C57Bl/6 mice transplanted with 
129/SvEv mouse myelogenous cells, and SvEvbkg/C57bm mice, hematopoietic tissue 
ablated 129/SvEv mice transplanted with C57Bl/6 mouse bone marrow cells. Six weeks 
after CaCl2-aneurysm induction, both chimeric mice produced aneurysms. However, the 
aneurysm sizes and pathological changes were similar to mice of their genetic 
background.  These results demonstrate that myelogenous cells are not responsible for 
the background specific differences in aneurysm size between the two mouse strains. 
Thus, the difference in aneurysm susceptibility is related to tissue properties, MMP 
expression, or some combination of both.   
A genetic predisposition to AAA formation is well-documented. 158,159 However, 
the genetic basis for this predisposition is unknown. Although animal models may not 
perfectly recapitulate human diseases, they can provide mechanistic insight toward 
understanding human pathology. The CaCl2-induced murine aneurysm model 
reproduces many features that have been clinically described in human AAA tissue, 
	   55 
including macrophage and T cell recruitment, MMP up-regulation, and elastin 
fragmentation. Studies have demonstrated that manipulation of MMP-2 and MMP-9 
levels have profound impacts on experimental aneurysm formation. 25,26 The current 
studies extend the previous work in demonstrating that even small differences in 
baseline or stimulated expression of MMP-2 and MMP-9 affect aneurysm size. Future 
studies examining factors regulating MMP gene expression will not only provide a 
greater understanding of the pathophysiology, but also may provide potential targets for 
therapeutic intervention. 
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CHAPTER 3 
 
 
 
Elastin-derived peptides enhance M1 macrophage polarization  
 
 
The following is a modified version of an article published in Journal of Immunology 2016 
This work was coauthored by Wanfen Xiong, Jeffrey S. Carson, Melissa K. Suh, Trevor 
M. Meisinger, George P. Casale, B. Timothy Baxter, and myself.   
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Introduction 
 A key feature associated with aneurysm formation is loss of ECM and the 
destruction of the aortic wall. ECM degradation leads to proteolysis of elastin, the 
predominant ECM protein in the aortic wall. 160 Elastin proteolysis releases elastin-
derived peptides (EDPs), including peptides with the xGxxPG motif, a commonly 
repeated sequence in elastin. 161 Of those EDPs released by elastin degradation, the 
VGVAPG repeat sequence in the human tropoelastin molecule has been shown to have 
the highest affinity for elastin-binding protein. 161-164 EDPs are upregulated in the serum 
of patients with AAA, and an increase in their level is predictive of AAA expansion. 
36,165,166 Previous reports have demonstrated that EDPs recruit inflammatory cells to sites 
of ECM damage and neutralizing their effect with BA4, a monoclonal antibody that binds 
to VGVAPG and other xGxxPG motifs, prevents elastin damage. 92,93,167,168 The precise 
mechanism through which EDPs affect macrophages and subsequently lead to 
enhanced tissue damage has not been fully elucidated.  
 Macrophages play critical roles in the innate immune system, responding to 
various stimuli in their microenvironment. They can exist in a pro-inflammatory M1 
phenotype as well as an anti-inflammatory M2 phenotype. 169 M1 macrophages are 
characteristically described by their release of pro-inflammatory cytokines, such as TNF-
α and IL-1β. TNF-α, has been shown to be required for experimental aneurysm 
formation in mice. 170 Previous studies have demonstrated an increase in M1 
macrophages in human AAA tissue. 36,37 In contrast, M2 macrophages are considered 
anti-inflammatory, aiding in the healing process by release of IL-10 and profibrotic 
factors such as TGF-β. 171 Their role in AAA formation and progression is less well 
known.  The chronic inflammatory process in AAA promotes aneurysm expansion by 
active ECM degradation and pro-inflammatory cell recruitment to areas of tissue 
damage, potentially caused by an abnormally high ratio of M1/M2 macrophages. Thus, 
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altering the M1/M2 ratio may play an important role in slowing or preventing AAA 
expansion.  
 The purpose of this study was to evaluate the role of the M1/M2 ratio in AAA and 
the effect of EDPs on macrophage polarization. These studies were performed by three 
different methods. First, EDPs were used to examine whether they polarize 
macrophages to a pro-inflammatory M1 or anti-inflammatory M2 phenotype in vitro. 
Next, M1 or M2 macrophages were injected into mice in order to directly alter the M1/M2 
ratio in the CaCl2 AAA model. Finally, the effect of direct inhibition of EDPs on AAA and 
macrophage polarization was examined by administration of BA4 after aneurysm 
induction.  
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Methods 
Reagents 
Monoclonal anti-elastin antibody BA4, IgG, soluble elastin, and LPS were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). VGVAPG peptide was purchased 
from Elastin Products Company (Owensville, MO, USA). Mouse IFN-γ and IL-4 were 
purchased from R&D systems (Minneapolis, MN, USA). 
 
Mouse aneurysm induction model 
The Institutional Animal Care and Use Committee (IACUC) approved all animal 
procedures. Male C57BL/6 mice at 8 weeks of age were obtained from The Jackson 
Laboratory (Bar Harbor, ME, USA). Mice underwent surgery as described previously. 172 
To induce AAA, mice were anesthetized with tribromethanol (250 mg/kg; Sigma Aldrich) 
and underwent laparotomy. The abdominal aorta between the iliac artery bifurcation and 
renal arteries was isolated from the surrounding retroperitoneal structures. Next, the 
external diameter of the abdominal aorta was measured in triplicate midway between the 
renal arteries and iliac artery bifurcation. After baseline measurements, periaortic 
application of 0.25 M CaCl2 was administered for 15 minutes followed by two washes 
with 0.9% sterile saline. Sterile saline (0.9% NaCl) replaced 0.25 M CaCl2 in sham 
control mice. The laparotomy incision was closed followed immediately by subcutaneous 
injections of buprenorphine (0.15 mg/ml) for analgesic after surgery.  
 
Anti-EDP antibody injections 
After aortic exposure, application of CaCl2, and closure of the laparotomy 
incision, antibody treatment was administered by intraperitoneal injection of BA4 (10 
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mg/kg) or IgG (10 mg/kg) in CaCl2-treated mice. NaCl-treated mice received no 
treatment after laparotomy. Weekly injections of BA4 or IgG continued for six weeks 
after initial injection. One week or six weeks after surgery, mice underwent laparotomy 
and isolation of the infrarenal aorta. Tissue from BA4-treated mice were harvested one 
week after aneurysm induction in order to allow one injection of the antibody to have its 
potential full effect based on previous work showing that 10 mg/kg of BA4 is still 
detectable in the serum one week after i.p. injection. 94 Measurements were repeated in 
triplicate at the same locations as baseline measurements. Mice were sacrificed and the 
entire infrarenal aorta was removed for protein or mRNA isolation or histological studies. 
For histological studies, aortic tissue was perfusion-fixed with 10% neutral buffered 
formalin.  
 
Bone marrow-derived macrophage isolation 
Bone marrow-derived macrophages (BMDMs) were isolated from C57Bl/6 or 
C57Bl/6J-Tg(UBC-GFP)30Scha/J (GFP) mice as described previously. 173 Briefly, mice 
were euthanized by cervical dislocation. The femur and tibia were isolated from the 
surrounding muscle tissue and sterilized in 70% ethanol for 15 seconds then washed in 
PBS (1x). The ends of each femur and tibia were removed and the bone marrow was 
flushed out with Dulbecco’s modified eagle medium (DMEM) supplemented with 1% fetal 
bovine serum (FBS) using a 25-gauge needle. Bone marrow cells were then passed 
through a cell strainer, washed with 1x PBS after centrifugation, then plated in a T75 
dish at 1x107 cells per 10 ml of BMDM media. BMDM media is defined as DMEM 
supplemented with 10% FBS, 20% conditioned medium from L929 cells (a source of M-
CSF), 1% Penicillin/Streptomycin, and 1% glutamine. BMDMs were grown at 37oC for 
seven days and media was removed and replaced with fresh BMDM media every two 
days. Flow cytometric analysis was used to determine purity of F4/80 positive 
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macrophages (98.6%). After seven days of growth, cells were treated for 24 hours with 
one of the five following treatments: No Tx (no treatment), M1 [IFN-γ (20 ng/ml) and LPS 
(100 ng/ml)], M2 [IL-4 (20 ng/ml)], EDP (1 µg/ml), or VGVAPG (1 µg/ml). Cell media was 
collected and RNA was isolated from the cells using TriZol according to manufacturer’s 
instructions. RNA levels were examined using qPCR analysis with SYBR Green 
(BioRad). GAPDH was used as an internal control.  
 
Bone marrow-derived macrophage polarization and injection 
Bone marrow cells were isolated and differentiated into macrophages as 
described above. After differentiation, BMDMs were treated with IFN-γ and LPS (M1) or 
IL-4 (M2). After polarization, 5x106 M1 or M2 BMDMs were injected into the mouse 
circulation via the tail vein. Mice were subjected to CaCl2-induced aneurysm induction 24 
hours after M1 or M2 injection. As a control, a group of mice received no M1 or M2 
macrophages prior to CaCl2 treatment. Mice were monitored for three days or six weeks. 
The three day-time point was chosen based on data presented in Supplemenatry Figure 
1, where expression of M1 and M2 associated markers are highest in the aortic tissue 
after application of CaCl2. Mice were sacrificed and the infrarenal aortic tissue was 
collected for histological, flow cytometry, RNA, or protein analysis.  
 
Histology and microscopy 
After perfusion-fixation with 10% neutral buffered formalin, aortic tissue samples 
were embedded in paraffin and sectioned into 4 µm sections. For Verhoeff-Van Gieson 
(VVG) staining, sections were stained with Verhoeff’s solution, ferric chloride, sodium 
thiosulfate, and Van Gieson’s solution. After each staining cycle, a fixing and washing 
procedure followed. Slides were then examined and photographed using light 
microscopy (40×; Nikon). Four sections were viewed per mouse.   
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Supplementary Figure 1. Aortic tissue mRNA levels of Ym1, CD206, and iNOS after 
aneurysm induction with CaCl2. Levels were examined at day zero, three days (D3), 
one week (D7), two weeks (D14), four weeks (D28), and six weeks (D42) after aneurysm 
induction (n = 3-4 aortas per group). GAPDH used as internal control. Data expressed 
as mean ± SEM.  
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Supplementary Figure 1. Aortic tissue mRNA levels of Ym1, CD206, and 
iNOS after aneurysm induction with CaCl2. Levels were examined at day 
zero, three days (D3), one week (D7), two weeks (D14), four weeks (D28), 
and six weeks (D42) after aneurysm induction (n = 3-4 aortas per group). 
GAPDH used as internal control. Data expressed as mean ± SEM.  
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Flow Cytometry 
Aortic tissue from mice was isolated and digested for one hour at 37oC with 
collagenase and elastase in RPMI with 1% FBS. 174 In order to isolate cells, the 
suspension from the digested tissue was filtered through a 40 µm filter. Cells were then 
pelleted by centrifugation and resuspended in flow cytometry staining buffer (1× PBS 
with 1% FBS). Cells were blocked with anti-mouse CD16/32 (1 µg/ml; BD Biosciences, 
San Diego, CA, USA) before surface labeling with the following antibodies: AlexaFluor 
700-labeled CD86 (BioLegend, San Diego, CA, USA) APC-labeled F4/80 (BioLegend) 
and RPE-labeled CD206 (Bio-Rad Laboratories, Hercules, CA, USA). Flow cytometry 
data were analyzed using BD FACSDIVA software.  
 
Detection of TNF-α concentration 
Bone marrow-derived macrophages were isolated as described above. Media 
was collected from cells after incubation with increasing doses of EDP (0.01, 0.1, 1.0, 
10, 100 µg/ml), VGVAPG (1 µg/ml), IFN-γ (20 ng/ml) and LPS (100 ng/ml), or IL-4 (20 
ng/ml) for 24 hours. Cell media was used in a TNF-α ELISA from R&D Systems 
(Minneapolis, MN, USA) according to manufacturer’s instructions.  
 
Immunofluorescence 
Mice that were injected with M1 or M2 macrophages were sacrificed at three 
days after aneurysm induction for macrophage staining performed on paraffin-embedded 
4 µm aortic sections. After deparaffinizing the sections, antigen retrieval was performed 
using Proteinase K (Viagen Biotech, Los Angeles, CA, USA; 20 µg/ml in TE buffer pH 
8.0). Sections were incubated in the Proteinase K working solution for three minutes at 
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room temperature. Sections were then washed and blocked with 10% normal goat 
serum. Rat monoclonal anti-F4/80 (ab6640, Abcam, Cambridge, MA, USA) diluted 1:400 
was applied to the sections and incubated at room temperature for one hour. Sections 
were then washed and incubated with AlexaFlour 488 goat anti-rat IgG (A-11006, Life 
Technologies, Grand Island, NY, USA) diluted 1:200 for one hour at room temperature. 
Slides were then mounted with ProLong gold antifade mountant with DAPI (P-36931, 
Life Technologies). Fluorescence images were captured with a Leica epifluorescence 
widefield microscope (DMRXA2) and CCD camera (Orca C4742; Hamamatsu 
Photonics, Bridgewater, NJ, USA), with Hamamatsu software (HCImage 4.0).  
 
Immunohistochemistry 
 Mice underwent AAA induction according to the method described above. Three 
to four mice from the NaCl, CaCl2-IgG, CaCl2-BA4 were sacrificed six weeks after 
aneurysm induction. Paraffin-embedded aortic sections were stained for CD206 (M2) 
and CD86 (M1). Sections were incubated with monoclonal rabbit anti-mouse CD86 
(Abcam) diluted 1/500 or monoclonal rabbit anti-mannose receptor (CD206; Abcam) 
diluted 1/100 for 30 minutes at 37oC. The sections were then briefly washed in citrate 
solution followed by incubation with a biotin-conjugated rat anti-rabbit IgG. CD206 and 
CD86 stained sections were examined by light microscopy (40×). The number of CD206 
or CD86 positive cells per high powered field were counted and displayed in a bar graph. 
Four separate sections from each aorta were stained and evaluated.  
 
Gelatin zymography 
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Aortic tissue protein was extracted as previously described and protein 
concentration was measured using the Bio-Rad protein assay (Bio-Rad Laboratories, 
Hercules, CA, USA). 175 Gelatin zymography was performed as previously described. 172 
Standardized protein samples (5 µg) were resolved by nondenaturing electrophoresis 
with 0.8% gelatin in a 10% SDS-polyacrylamide gel. Molecular sizes of gelatinolytic 
activity were determined using protein standards (Bio-Rad). Signal intensities were 
quantified using ImageJ version 1.38x software (NIH, Bethesda, MD, USA).  
 
Statistical analysis 
The change in external aortic diameter over the course of aneurysm 
development was compared to baseline for each animal, and results for each group 
were expressed as mean ± SEM. ANOVA and post-hoc t-test with Bonferroni’s 
correction were used to compare multiple groups. Statistical significance was accepted 
at a P-value < .05. 
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Results 
Elastin-derived peptides promoted a pro-inflammatory M1 phenotype  
To determine the role that EDPs have on macrophage phenotype, bone marrow 
cells were isolated and differentiated into BMDMs. To establish control M1 or M2 cells, 
BMDMs were treated with IFN-γ and LPS (M1), IL-4 (M2), or left untreated (No Tx) for 24 
hours (Fig. 1A). To examine the effect of elastin fragments on macrophage polarization, 
BMDMs were treated with 1 µg/ml of EDPs or VGVAPG for 24 hours. EDP and 
VGVAPG treatment induced mRNA expression of M1 associated markers, such as TNF-
α and IL-1β (Fig. 1A). In contrast, mRNA expression of M2 markers, CD206 and Ym1, 
was not affected by EDP or VGVAPG treatment (Fig. 1A). MMP-9 mRNA expression 
was also increased by EDP or VGVAPG treatment (Fig. 1A). To determine if the EDP-
mediated M1 polarization was concentration dependent, BMDMs were treated with 
increasing doses of EDPs. An ELISA demonstrated a stepwise increase in TNF-α levels 
in the media with increasing doses of EDPs (Fig. 1B).   
 
M2 macrophages reduced aortic dilation in an experimental AAA model  
To determine the in vivo effects of influencing the M1/M2 ratio in an experimental 
AAA model, macrophages polarized to the M1 or M2 phenotype were injected 
intravenously into mice 24 hours prior to aneurysm induction. Cells were sampled from 
each treatment group prior to injection and M1 or M2 polarization was confirmed by 
protein expression of M1 (iNOS) and M2 (Ym1) markers (Fig. 2B). A control group of 
mice underwent aneurysm induction without injection of macrophages (Control). Aortic 
diameters were measured six weeks after aneurysm induction. Three of the eight mice 
that received M1 macrophages were sacrificed prior to the six-week time point due to 
severe systemic illness; necropsy revealed severe aortic damage in these mice. All of 
the mice that received M2 macrophages (9/9) survived to the six-week time point.  
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Figure 1. Elastin-derived peptides polarize macrophages to a pro-inflammatory M1 
phenotype. A) qPCR analysis of M1 and M2 phenotype markers after treatment of 
macrophages with IFN-γ and LPS (M1), IL-4 (M2), VGVAPG (1 µg/ml), or EDP (1 µg/ml) 
for 24 hours. GAPDH was used as an internal control. B) ELISA measurement of TNF-α 
levels from EDP- or VGVAPG-treated macrophage media. Statistics performed using 
ANOVA and Student’s t-tests. Data expressed as mean ± SEM. *, P < .05; **, P < .01 
versus no treatment (No Tx).  
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Figure 2. M1 and M2 macrophage influence on aortic size six weeks after 
aneurysm induction. A) Schematic representation of method of BMDM isolation, 
injection, and aortic aneurysm induction. B) Representative image of protein expression 
of M1 (iNOS) or M2 (Ym1) markers of macrophages treated with IFN-γ (20 ng/ml) and 
LPS (100 ng/ml) or IL-4 (20 ng/ml) prior to injection. C) Aortic diameter percent increase 
six weeks after aneurysm induction with M1 or M2 macrophage injection (n = 5-9 per 
group). Statistics performed using ANOVA and Student’s t-tests. Data expressed as 
mean ± SEM. *, P < .05; **, P < .01. D) Representative VVG images of aortas six weeks 
after aneurysm induction with injection of  M1, M2, or no macrophages (Control) (n = 3-4 
per group). VVG image of aorta from a mouse that required sacrifice within one week 
after aneurysm induction. Arrows indicate sites of elastin fragmentation.  
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Figure 2. M1 and M2 macrophage influence on aortic size six weeks after 
aneurysm induction. A) Schematic representation of method of BMDM 
isolation, injection, and aortic aneurysm induction. B) Representative image 
of protein expression of M1 (iNOS) or M2 (Ym1) markers of macrophages 
treated with IFN-γ (20 ng/ml) and LPS (100 ng/ml) or IL-4 (20 ng/ml) prior to 
injection. C) Aortic diameter percent increase six weeks after aneurysm 
induction with M1 or M2 macrophage injection (n = 5-9 per group). Statistics 
performed using ANOVA and Student’s t-tests. Data expressed as mean ± 
SEM. *, P < .05; **, P < .01. D) Representative VVG images of aortas six 
weeks after aneurysm induction with injection of  M1, M2, or no 
macrophages (Control) (n = 3-4 per group). VVG image of aorta from a 
mouse that required sacrifice within one week after aneurysm induction. 
Arrows indicate sites of elastin fragmentation.  
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Comparing survival (5/8 vs. 9/9) between the two groups by Fisher’s exact test 
demonstrated a P-value of 0.08. While M1 macrophage injection did not show a 
statistically significant increase in aortic diameter, the trend toward larger aneurysms 
may have been attenuated by the three mice that required sacrifice prior to six weeks. 
The aortic diameters from mice injected with M2 macrophages were significantly smaller 
than CaCl2-treated control mice or mice injected with M1 macrophages (Fig. 2C). 
Connective tissue staining indicated robust elastin degradation in aortas from the M1 
injected mice compared to CaCl2-treated control mice. The most severe elastin 
degradation was seen in mice sacrificed prior to the six-week time point (Fig. 2D). Aortas 
from M2-injected mice displayed overall elastin preservation six weeks after aneurysm 
induction (Fig. 2D). The elastin preservation seen in these animals coincided with a 
decrease in levels of both MMP-9 and MMP-2 in M2-injected mice compared to M1-
injected mice (Fig. 3). No differences in MMP levels were seen between Control and M1-
injected mice.  
 
Infleunce of M1 and M2 macrophages at three days  
To determine the effect of M1 or M2 macrophages on early aortic aneurysm 
formation, CaCl2- or NaCl-treated mice that had undergone M1 or M2 injection were 
sacrificed three days after aneurysm induction. The effect of the M2 macrophages 
observed at six weeks was also seen at the earlier three-day time point (Fig. 4B). In 
contrast to the six-week time point, M1 macrophage injection did show a significant 
increase in aortic diameter compared to CaCl2-treated control mice. M1 or M2 injection 
had no effect on aortic diameter in NaCl-treated mice (Fig. 4B). In order to assess that 
the injection of M1 or M2 cells were having a local effect on the macrophage population 
in the aortic tissue, cells were isolated from the aorta by enzymatic digestion three days 
after aneurysm induction. Cells were analyzed by flow cytometry to determine the ratio  
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Figure 3. Active MMP-2 and MMP-9 levels are decreased in mice injected with M2 
macrophages. Signal intensities of ProMMP-9 MMP-9, ProMMP-2, and MMP-2 were 
quantified using ImageJ software. Statistics performed using ANOVA and Student’s t-
tests. Data are presented as mean ± SEM (n = 4-5 aortas per group). *, P < .05. 
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Figure 3. Active MMP-2 and MMP-9 levels are decreased in mice injected 
with M2 macrophages. Signal intensities of ProMMP-9 MMP-9, ProMMP-2, 
and MMP-2 were quantified using ImageJ software. Statistics performed 
using ANOVA and Student’s t-tests. Data are presented as mean ± SEM (n = 
4-5 aortas per group). *, P < .05. 
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Figure 4. M1 and M2 macrophage influence on aortic size three days after 
aneurysm induction. A) Schematic representation of methods three days after 
aneurysm induction and macrophage injection. B) Aortic diameter percent increase three 
days after aneurysm induction with injection of M1, M2, or no macrophages (Control) (n 
= 5-6 per group). NaCl was used as sham control. C) Bar graph on left represents 
M1/M2 ratio of M1 (CD86) to M2 (CD206) positive macrophages (F4/80) from flow 
cytometry (n = 5-6 per group). Right bar graph shows proportion of F4/80+ macrophages 
found in tissue. D) Representative immunofluorescence and VVG stained images of 
aortas three days after surgery and M1 or M2 macrophage injection (n = 3 per group). 
Top panel shows aortas stained with a rat anti-mouse F4/80 antibody (red), cell nuclei 
stained with DAPI (blue); bottom panel shows VVG stained aortas. Arrows indicate sites 
of elastin fragmentation or abnormal structure. Statistics performed using ANOVA and 
Student’s t-tests. Data expressed as mean ± SEM. *, P < .05; **, P < .01.  
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Figure 4. M1 and M2 macrophage influence on aortic size three days after 
aneurysm induction. A) Schematic representation of methods three days after 
aneurysm induction and macrophage injection. B) Aortic diameter percent 
increase three days after aneurysm induction with injection of M1, M2, or no 
macrophages (Control) (n = 5-6 per group). NaCl was used as sham control. C) 
Bar graph on left represents M1/M2 ratio of M1 (CD86) to M2 (CD206) positive 
macrophages (F4/80) from flow cytometry (n = 5-6 per group). Right bar graph 
shows proportion of F4/80+ macrophages found in tissue. D) Representative 
immunofluorescence and VVG stained images of aortas three days after surgery 
and M1 or M2 macrophage injection (n = 3 per group). Top panel shows aortas 
stained with a rat anti-mouse F4/80 antibody (red), cell nuclei stained with DAPI 
(blue); bottom panel shows VVG stained aortas. Arrows indicate sites of elastin 
fragmentation or abnormal structure. Statistics performed using ANOVA and 
Student’s t-tests. Data expressed as mean ± SEM. *, P < .05; **, P < .01.  
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of M1 to M2 polarized cells (Fig 4C). These data demonstrated a higher M1/M2 ratio in 
the aortas of M1-injected mice and a decreased ratio in M2-injected mice. By 
immunofluorescence staining, there did not appear to be a difference in the total number 
macrophages in aortic tissue when comparing M1- to M2-injected mice (Fig. 4D). This 
was consistent with flow cytometry data showing no difference in the percentage of 
F4/80+ macrophages in the aortic tissue. Connective tissue staining revealed that M1 
macrophage injection resulted in severe elastin fragmentation three days after aneurysm 
induction; the corresponding immunofluorescence studies indicated a high concentration 
of macrophages adjacent to the sites of marked elastin damage (Fig. 4D). Aortas from 
M2-injected mice showed preserved elastin architecture.   
In order to determine whether injected macrophages migrated to the aorta, GFP+ 
BMDMs were incubated with IFN-γ and LPS (M1) and IL-4 (M2). After polarization, GFP+ 
M1 or GFP+ M2 cells were injected intravenously into mice 24 hours prior to aneurysm 
induction. Aortic tissue was harvested three days after aneurysm induction, digested, 
and a single cell suspension was analyzed by flow cytometry. GFP+ cells were found in 
aortas of 6/7 mice injected with M1 cells and 5/6 mice injected with M2 cells. Further 
analysis revealed that 1.18% ± 0.22 of the total M1 cells detected in the M1-injected 
mice were GFP+ and that 9.25% ± 2.74 of the total M2 cells detected in the M2-injected 
mice were GFP+.  
 
BA4 reduced aortic diameter and elastin degradation 
BA4 is a monoclonal antibody that specifically binds xGxxPG motifs, particularly 
VGVAPG, which is a common motif repeated in elastin. Previous studies have shown 
that BA4 reduces monocyte/macrophage chemotaxis in diseases associated with elastin 
fragmentation, such as Marfan syndrome and emphysema. 92,94 To determine if BA4 can 
reduce aortic dilation in AAA, mice were treated with weekly i.p. injections of BA4 (10  
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Figure 5. BA4 attenuates aortic dilation and elastin degradation. A) Schematic 
representation of methods for weekly anti-EDP treatment. B) Percent increase in aortic 
diameter six weeks after aneurysm induction and treatment with IgG or BA4 (n = 7-8 
mice per group). C) Representative gelatin zymogram of mouse aortic tissue six weeks 
after aneurysm induction. Signal intensities of MMP-2, ProMMP-2, and MMP-9 were 
quantified using ImageJ software. Statistics performed using ANOVA and Student’s t-
tests. Data are presented as mean ± SEM (n = 4-5 aortas per group). *, P < .05; **, P < 
.01. C) Representative VVG staining of aortic tissue sections from NaCl, CaCl2 IgG, and 
CaCl2 BA4 treated mice (n = 3-4 aortas per group). Arrows indicate sites of elastin 
damage. 
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Figure 5. BA4 attenuates aortic dilation and elastin degradation. A) 
Schematic representation of methods for weekly anti-EDP treatment. B) 
Percent increase in aortic diameter six weeks after aneurysm induction and 
treatment with IgG or BA4 (n = 7-8 mice per group). C) Representative 
gelatin zymogram of mouse aortic tissue six weeks after aneurysm induction. 
Signal intensities of MMP-2, ProMMP-2, and MMP-9 were quantified using 
ImageJ software. Statistics performed using ANOVA and Student’s t-tests. 
Data are presented as mean ± SEM (n = 4-5 aortas per group). *, P < .05; **, 
P < .01. C) Representative VVG staining of aortic tissue sections from NaCl, 
CaCl2 IgG, and CaCl2 BA4 treated mice (n = 3-4 aortas per group). Arrows 
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mg/kg) after CaCl2 aneurysm induction. A control group of mice received weekly 
injections of non-specific IgG (10 mg/kg). Six weeks after aneurysm induction, mice were 
sacrificed and aortas harvested for analysis. BA4 reduced aortic dilation compared to 
IgG treatment (Fig. 5B). Active forms of both MMP-9 and MMP-2 in aortic tissue were 
also decreased in BA4-treated mice, whereas the inactive form of MMP-2 was not 
significantly reduced (Fig. 5C). Connective tissue staining revealed general elastin 
preservation in aortas from BA4-treated mice (Fig. 5D). Treatment with NaCl had no 
effect on elastin fragmentation. Immunohistochemical staining revealed an increase in 
CD206 positive cells (M2 macrophage marker) in aortic tissue from BA4-treated mice 
compared to NaCl and IgG-treated mice (Supplementary Fig. 2). The number of CD86 
positive cells was higher in aortas from IgG-treated mice but not significantly different 
from NaCl or BA4-treated mice.  
 In order to better understand the early pathogenesis of aneurysm formation, the 
effects of EDP neutralization were evaluated one week after aneurysm induction. Aortic 
diameter was increased in both BA4-treated and IgG-treated mice; however, IgG-treated 
mice exhibited a markedly greater increase in diameter (Fig. 6A). A previous study 
showed that monocyte/macrophage chemotaxis in response to human AAA explants 
was reduced by preincubation of the tissue with BA4. 167 In this present study, BA4’s 
ability to reduce macrophage migration in vivo was assessed by flow cytometry. As 
expected, migration of F4/80+ macrophages to aortic tissue was increased after CaCl2-
IgG treatment compared to NaCl treatment (Fig. 6B). BA4 reduced the frequency of 
macrophage migration to the baseline levels seen in NaCl-treated aortas. Gelatin 
zymography demonstrated that BA4 treatment reduced the active forms of both MMP-2 
and MMP-9 in aortic tissue at one week (Fig. 6C). M1 or M2 polarization was assessed 
in aortic tissue after CaCl2 treatment. Quantitative PCR revealed downregulation of M1 
associated genes (TNF-α, CD86) and upregulation of M2 associated genes (CD206,  
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Supplementary Figure 2. BA4 increases CD206+ macrophages in aortic tissue. 
Representative immunohistochemisty of CD206 or CD86 positive cells in aortic tissue six 
weeks after aneurysm induction. Bar graph represents number of CD206 or CD86 
positive cells per high powered field (HPF). The anti-CD86 antibody demonstrated some 
nonspecific binding to connective tissue. Arrows indicate representative CD206 or CD86 
positive cells. Statistics performed using ANOVA and Student’s t-tests. Data are 
presented as mean ± SEM (n = 4-5 aortas per group). *, P < .05; **, P < .01. 
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Figure 6. BA4 reduced macrophage migration, MMP production, and the ratio of 
M1/M2 markers in aortic tissue one week after aneurysm induction. A) Percent 
increase aortic diameter one week after aneurysm induction (n = 8-10 per group). B) 
Number of F4/80 positive cells in NaCl, CaCl2-IgG, and CaCl2-BA4 treated aortas (n = 7-
8 per group). C) Representative gelatin zymogram of aortic tissue one week after 
aneurysm induction. Bar graphs represent signal intensities of ProMMP-9, MMP-9, 
ProMMP-2, and MMP-2 by quantification with ImageJ software (n = 3-4 per group). Data 
expressed as mean ± SEM. *, P < .05; **, P < .01. D) Fold change in mRNA expression 
of M1 and M2 associated markers from aortic tissue of mice treated with CaCl2-IgG or 
CaCl2-BA4 compared to NaCl-treated mice one week after aneurysm induction (n = 4 
per group). GAPDH was used as internal control. Dashed line indicates NaCl control 
(fold change = 1). Statistics performed using ANOVA and Student’s t-tests.  Data 
expressed as mean ± SEM. *, P < .05; **, P < .01 versus NaCl. †, P < .05; ††, P < .01 
versus CaCl2-IgG treatment.   
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Ym1) with BA4 treatment (Fig. 6D). Many typical pro-inflammatory markers identified in 
aneurysm tissue were decreased by BA4 treatment (Supplementary Fig. 3A) while anti-
inflammatory markers were increased (Supplementary Fig. 3B). By Western blot 
analysis, the M2-associated marker Ym1 was increased in BA4-treated aortic tissue 
compared to IgG treatment (Supplementary Fig. 4).  
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Supplementary Figure 3. BA4 treatment promotes an anti-inflammatory 
environment in aortic tissue one week after aneurysm induction. A) Bar graphs 
represent fold change in mRNA expression levels of pro-inflammatory and M1 
associated markers from aortic tissue relative to NaCl controls (dashed line) one week 
after surgery. B) Bar graphs represent fold change in mRNA expression levels of anti-
inflammatory and M2 associated markers from aortic tissue relative to NaCl controls 
(dashed line) one week after aneurysm induction (n = 4 per group). GAPDH was used as 
internal control. Statistics perfumed using ANOVA and Student’s t-tests. Data expressed 
as mean ± SEM. *, P < .05; **, P < .01 versus NaCl. †, P < .05; ††, P < .01 versus 
CaCl2-IgG treatment.  
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Supplemental Figure 3 
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Supplementary Figure 4. Aortic tissue protein levels of Ym1 one week after BA4 
treatment. Bar graph represents relative protein expression levels of Ym1 one week 
after aneurysm induction and IgG or BA4 treatment (n = 4 aortas per group). GAPDH 
used as internal control. Statistics perfumed using ANOVA and Student’s t-tests. Data 
expressed as mean ± SEM. *, P < .05.  
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BA4 treatment. Bar graph represents relative protein expression levels of 
Ym1 one week after aneurysm induction and IgG or BA4 treatment (n = 4 
aortas per group). GAPDH used as internal control. Statistics perfumed 
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Discussion 
Using a murine model of AAA, we found that M1 macrophages strongly promoted 
aneurysm formation. This effect was seen as early as three days after aneurysm 
induction; aortic diameters were larger in the M1-infused group. This increase was not 
significant compared to CaCl2-treated control at six weeks. This may be explained, 
however, by the fact that three of the eight mice treated with M1 macrophages required 
sacrifice within one week of aneurysm induction due to severe systemic illness. Post-
mortem examination of the aortic tissue from these three mice demonstrated severe 
elastin damage not typically seen until six weeks. This early morbidity is atypical for this 
model and was not seen in any of the M2-treated mice, suggesting that an excess 
number of M1 macrophages may be toxic. Conversely, M2 macrophage infusion was 
highly protective against elastin degradation and aneurysm formation. Furthermore, 
EDPs, systemic levels of which are elevated in AAA patients, 176 promoted polarization of 
macrophages to a pro-inflammatory M1 phenotype. EDPs also enhanced the 
transcription of MMP-9, which has previously been shown to be required for AAA 
development. 172,177 In vitro studies showed that EDPs or the VGVAPG peptide did not 
upregulate expression of M2-associated genes. Administration of the antibody BA4, 
which binds the repeated elastin motif VGVAPG, dramatically reduced aortic dilation, 
elastin fragmentation, and MMP production. BA4 lowered M1 and raised M2 markers 
early after aneurysm induction, leading to a reduction in aneurysm formation at six 
weeks. 
 EDPs are created as a result of breakdown of elastin, a key extracellular matrix 
protein that is present in the skin, lungs, arteries, and other structures. Elastin makes up 
50% of the aortic wall proteins by weight. 178 Once elastin is incorporated into the tissue 
structure, there is little to no turnover except under pathological conditions. 92,179-181 
Previous studies have shown that EDPs are increased in the serum of patients with 
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AAAs. 165,166,176 EDPs have been shown to have inflammatory properties by examination 
of their effects on lymphocytes and MMP expression; they increase Th1 associated 
cytokines and MMP-9 synthesis. 182 This polarization of lymphocytes appears to be 
mediated through a receptor for specific EDPs, since it can be blocked by neutralization 
of the elastin receptor or with lactose, which causes shedding of the receptor from the 
cell membrane. 161 Similar treatment inhibited monocyte migration when monocytes were 
exposed to human AAA tissue extract. 167 A previous study has suggested that EDPs 
may have an anti-inflammatory effect on macrophages under specific conditions. 183 In 
contrast, the present study indicated that EDPs had a profound pro-inflammatory effect. 
Furthermore, we demonstrated that this effect was mediated by promoting M1 
macrophage polarization.  
 Chronic inflammation occurs in the aortic tissue of patients with AAA; the 
predominate cell types found in this infiltrate are T lymphocytes and macrophages. 30,184 
Inflammation induced by ablumenal application of CaCl2 in a model of AAA recapitulates 
many features seen in human AAA tissue including macrophage and lymphocyte 
infiltration, MMP upregulation, elastin degradation, and aortic dilation. 31,155,172,185 Pro-
inflammatory M1-associated cytokines such as TNF-α, IL-6, and IFN-γ are increased in 
both human and experimental AAAs. 36,37 Deletion or neutralization of these M1-
associated cytokines resulted in reduced aortic dilation or complete aneurysm inhibition. 
100,101,170,175 M1 or M2 macrophage polarization can have a significant role in regulating 
chronic inflammatory processes; little is known about the role of M1 or M2 macrophage 
polarization in aortic aneurysms. We demonstrated that the pro-inflammatory state 
induced by CaCl2 was enhanced by supplementation with M1-polarized macrophages. 
M2 macrophage injection rescued the aorta from expansion and elastin disruption. The 
pathogenesis of aneurysm development was altered early in its course by M2 
macrophages, where the impact on aortic dilation and elastin fragmentation could be 
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seen as early as three days after aneurysm induction. Taken together, these data 
demonstrate that the M1/M2 ratio plays a fundamental role in aneurysm development, 
and could prove an important therapeutic target.  
 By using flow cytometry, we were able to determine that injected macrophages 
are able to migrate to the damaged aorta. This small proportion of injected cells found in 
the aorta three days after aneurysm induction may not completely account for how these 
cells induce the distinct aortic phenotypes observed. It is known that small populations of 
cells, such as T regulatory cells, can have a major effect on inflammatory processes in 
both human and murine AAAs. 76,186 These injected M1 or M2 cells may also be acting 
systemically by increasing circulating levels of cytokines levels vital to aneurysm 
formation. Injection of M1 macrophages led to early mortality in three mice within a week 
of aneurysm induction suggesting a profound systemic inflammatory response not seen 
in M2-injected mice.  These injected M1 or M2 cells may also be influencing other cell 
types important in aneurysm formation such as T regulatory cells. 187 In the case of 
injected M2 cells, they may be creating a positive feedback loop by enhancing other anti-
inflammatory cell populations. These populations may further enhance the M2 
phenotype leading to decreased damage to the aortic wall and preservation of elastin. 
Previous studies have shown that macrophages are not terminally differentiated and 
have the ability to change phenotypes over time. 188-190 Future studies will focus on better 
understanding these mechanisms and, particularly, the potential benefit of injecting 
macrophages polarized to the M2 phenotype.  
The elastin-binding protein is assumed to have a role in normal elastin assembly 
by secreting the elastin precursor, tropoelastin, into the ECM. 191 This protein is found on 
many cell types, including cells that don’t normally produce elastin. 192 This study 
suggests that the elastin-binding protein, through its interaction with EDPs, contributes to 
disease pathogenesis when present on inflammatory cells such as macrophages. 
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Previous studies have shown that the peptide sequence predominantly recognized by 
the elastin-binding protein is VGVAPG. Other peptides of this motif, xGxxPG, have a 
lower affinity for the elastin-binding protein. 193 These particular motifs are found primarily 
in elastin, but are also present to a lesser extent in other connective tissue proteins. 
Binding of the BA4 antibody to elastin fragments with the xGxxPG motif reduces or 
inhibits cellular activation in response to the presence of EDPs. 92-94,167, 194 In this study, 
we demonstrate this critical role of EDPs in potentiating aneurysm formation, in part, 
through the elastin-binding protein on macrophages. The in vitro studies indicated that 
the mechanism for this effect is mediated by altering macrophage polarization. As 
expected, BA4 reduced macrophage migration to the site of aortic injury. Importantly, the 
BA4 treatment also influenced production of M1 and M2 related proteins, reducing the 
pro-inflammatory microenvironment caused by EDPs. Since M2 macrophages are 
known to play a role in healing, the effects seen with BA4 may represent attempted 
tissue repair.  
 In conclusion, this study demonstrated that EDPs have an important role in 
promoting aneurysm expansion by altering the macrophage phenotype. This increase in 
M1/M2 ratio would be expected to create a positive feedback loop by further degradation 
of the elastin matrix and continued release of EDPs. The profound inhibitory effects of 
the M2 macrophages suggest a key role in preventing small aneurysm expansion. All 
current treatments for aortic aneurysms rely on mechanical intervention. Yet, when most 
AAAs are detected, they are below the threshold for repair leading to a significant 
observation period during which there is currently no medical therapy to prevent or slow 
aneurysm growth. The results presented herein suggest that decreasing the M1/M2 
ratio, either by neutralization of pro-inflammatory EDPs or enhancing the anti-
inflammatory environment created by M2 macrophages, could prove a useful therapeutic 
target for small aortic aneurysms.   
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DISSERTATION DISCUSSION 
The course of human AAA is a long, complex, and multifactorial process. Most 
patients are asymptomatic until the AAA ruptures, which 90% of the time results in 
death. 195 Of those patients that have been diagnosed and are aware of their aneurysm, 
a period of cautious waiting occurs until the aneurysm is dilated enough to need surgical 
intervention. While advances in surgical techniques have reduced the immediate 
complications after open aneurysm repair, 196 the game of waiting for this ticking time 
bomb to rupture needs to become obsolete. Therefore, the need for pharmacological 
intervention is critical in order to prevent the progression or stimulate the regression of 
established AAAs. Clinical trials are underway in order to identify a therapeutic 
alternative to mechanical AAA intervention.  
Studies on human AAA tissue focus on the end stage of disease since the tissue 
is obtained most often at the time of open aneurysm repair when the aorta is significantly 
enlarged and damaged. In addition, the ability to obtain human AAA tissue is decreasing 
as endovascular AAA repair increases. Therefore, in order to study AAA pathogenesis, 
animal models must be used. The three most commonly used murine AAA models are 
the ApoE-/- angiotensin-II infusion model, elastase perfusion, and CaCl2 topical 
application. The CaCl2 model is able to recapitulate many characteristics similar to 
human AAA such as elastin degradation, inflammatory cell infiltration, and MMP 
upregulation. This model and the elastase perfusion model are less widely used due to 
their technical challenges compared to the ApoE-/- angiotensin-II infusion model. 
Regardless of the AAA model used, these murine models are considered to be acute 
models that cannot completely capture the chronic inflammatory disease process 
occurring in human AAAs.  
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By using the CaCl2 aneurysm model on two different strains of mice, C57Bl/6 and 
129/SvEv, the dissimilarities seen in aortic growth, MMP production, and inflammatory 
cell infiltration can mimic the heterogeneity seen between patients with AAAs. These 
important findings show that baseline and activated MMP differences seen between the 
129/SvEv and C57Bl/6 mice have a vital role in the aortic growth rate. These data can 
help to explain why one patient’s aneurysm may grow at a faster rate than another’s. 
Aortic diameter can provide important information as to how susceptible the patient may 
be to aortic rupture. Being able to produce larger aneurysms in the 129/SvEv mouse 
could help to recreate the characteristics observed in tissue taken from large human 
AAAs obtained at the time of surgery. These larger aneurysms could also recapitulate 
the pathological processes occurring in human patients at the time of aneurysm rupture 
since a large aneurysm diameter is predictive of the susceptibility to rupture.  
Specific genetic linkages are known for thoracic aortic aneurysms, such the 
fibrillin-1 mutation in MFS or the TGF-β receptor 1 mutation in Loeys-Dietz syndrome. 
Heredity influences AAA susceptibility, however, a specific genetic linkage for the 
susceptibility to AAA formation has not yet been discovered. Moreover, it is not yet 
known why male siblings of known patients have a greater risk of developing AAAs. 197 
Recent studies have identified mutations in kallikrein 1, a serine protease, or MMP-3 as 
genetic loci associated with AAA formation. 198,199 The increased levels of Pro-MMP-2 at 
baseline and six weeks after aneurysm induction in mice indicate that these proteases 
are vital to the growth rate of aneurysm formation. The differences seen in aneurysm 
size between the 129/SvEv and C57Bl/6 mice may not simply be due to a mutation in 
MMP-2, as implied by the kallikrein 1 and MMP-3 mutations identified in human AAA, but 
also due to the pathways involved in MMP-2 activation. Since the activated levels of 
MMP-2 in 129/SvEv mice were no different from C57Bl/6 mice prior to aneurysm 
induction but significantly increased six weeks after application of CaCl2, these data 
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imply a difference in the activation pathway associated with MMP-2. Previous studies 
demonstrate that membrane-type 1 MMP cleaves Pro-MMP-2 to active MMP-2 and that 
membrane- type 1 MMP levels were elevated in human AAA tissue. 200 Mice deficient in 
membrane-type 1 MMP were unable to form aneurysms. 135 The results presented herein 
indicate that future directions should be focused not just on inactivation of MMPs, but 
also on pathways leading to MMP activation.  
Knowledge of pathways and proteases associated with ECM degradation is 
critical to understand the destruction process associated with AAA formation. 
Investigation of the reparative process is equally as important in developing therapeutic 
targets. Stopping the aortic wall degradation process is important in preventing 
aneurysms from growing large enough to rupture, but this does not fix the damaged 
structural integrity of the aortic wall. Focus should also be directed to promoting 
pathways associated with aortic repair, where restoration of a healthy aortic diameter is 
the objective. The differences in tropoelastin observed between C57Bl/6 mice and 
129/SvEv mice demonstrate unequal reparative processes. C57Bl/6 mice express higher 
levels of tropoelastin, which may answer why these mice develop smaller aneurysms 
and exhibit reduced elastin degradation compared to 129/SvEv mice that underwent the 
same treatment. While baseline levels of tropoelastin indicate no difference in protein 
expression between C57Bl/6 and 129/SvEv mice, increased levels of tropoelastin are 
seen in the C57Bl/6 mice six weeks after aneurysm induction. These data demonstrate 
that pathways associated with ECM deposition, specifically elastin deposition, are 
increased. Human AAA tissue expresses lower levels of tropoelastin than human tissue 
from an atheromatous plaque, indicating that an inability to properly repair the damaged 
aorta may be leading to outward remodeling and aneurysm formation. 201  
The genetic differences seen between these two strains of mice imply that the 
reason why some patients develop AAA while others develop atherosclerotic plaques 
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may not only be due to differences in proteolytic process but also due to differences in 
reparative processes. Therapeutic targets enhancing proper tissue repair is vital to 
correcting the abnormal aortic dilation. This process will undoubtedly be quite difficult 
considering the formation of mature elastin is complex. Many proteins, such as fibrillin-1, 
fibronectin, and lysyl oxidase are involved in the proper formation of mature elastin while 
specific timing associated with their expression is critical. 202 Recreating the complex 
temporal, spatial, and structural interactions for proper elastin fiber assembly will be 
challenging. If all of the proteins are not deposited in the proper quantities and proper 
order, the repaired aorta will likely be prone to aneurysm formation as evidenced in MFS 
where fibrillin-1 deficiency results in ascending aortic aneurysm formation. Producing 
enough elastin to combat the proteolytic process produced by MMPs is essential, but 
producing too much elastin may create complications as evidenced by the release of 
EDPs.  
Elastin is the major ECM protein responsible for maintaining an artery’s elastic 
properties. These mechanical properties are important for small to medium sized arteries 
ability to maintain blood pressure. Elastin in larger arteries, such as the aorta, has a role 
in load bearing in relation to tension in the aortic wall. 203 As seen in the data presented 
herein, breakdown of elastin in these larger arteries results in release of EDPs, which 
promote pro-inflammatory M1 macrophage polarization. Serum from patients with AAAs 
has higher levels of EDPs when compared to serum from patients with other vascular 
diseases such as atherosclerosis. The initial damage to the aortic wall likely results in 
release of EDPs into the blood stream, creating a pro-inflammatory environment and 
enhancing the chronic inflammation associated with AAAs. Whether AAA is caused by 
genetics, patient lifestyle, or some traumatic event, release of these EDPs most certainly 
exacerbates disease progression. Targeting these free floating or exposed elastin 
fragments could prove to be a useful therapeutic target in slowing the rate of aneurysmal 
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growth or even stimulating aneurysm regression. Stopping these EDPs from creating a 
pro-inflammatory environment or directly altering the ratio of pro-inflammatory M1 cells 
to anti-inflammatory M2 cells are exciting new prospects in understanding the disease 
process. The data presented demonstrates that blocking EDPs could be a therapeutic 
target. Not only does neutralization of EDPs with BA4 reduce MMP activity, but it also 
limits the recruitment of macrophages to the aortic wall. Of those macrophages that were 
able to infiltrate the mouse aortic wall, a higher number of alternatively activated M2 cells 
were present in BA4-treated mice than classically activated M1 cells. The pro-
inflammatory environment commonly found in the aortic wall of this animal model had 
switched to an anti-inflammatory environment by neutralization of EDPs, potentially 
promoting tissue repair. Further investigation into how neutralization of EDPs affects 
already established mouse aneurysms is needed. This scenario would better 
recapitulate the stage of the disease typically found in patients diagnosed with AAAs. 
Determining what effect EDP neutralization has on other cell types in the aortic wall is 
also important, since the phenotype of T cells or SMCs have also been found to play a 
role in AAA formation and repair.  
While AAAs have a complex and multifactorial disease process, studies have 
been able to identify common inflammatory cells found in the aneurysmal wall. CD4+ T 
cells can exist in many different phenotypes ranging from the pro-inflammatory Th1 or 
Th17 cells to the anti-inflammatory Th2 or Treg cells. Serum samples from patients with 
AAA have demonstrated a deficiency in the anti-inflammatory Treg population when 
compared to age- and sex-matched controls.76 Furthermore, animal studies have 
demonstrated that the deletion or expansion of Treg cells can have harmful or beneficial 
effects on aneurysm formation, respectively. 204,205 The same could be true for 
macrophages. Whether there is a deficiency in anti-inflammatory M2 macrophages 
circulating in serum from AAA patients or in AAA tissue compared to disease-matched 
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patients has yet to be determined. Conflicting data exists concerning the phenotype of 
macrophages found in human AAA tissue. By using the CaCl2 AAA model, we 
demonstrated that macrophages are pro-inflammatory after the initial insult, and then 
may progress to a more anti-inflammatory phenotype over time. The proportion of 
M1/M2 cells is vital at various time points along the course of the disease progression. 
By directly altering that M1/M2 phenotype ratio through tail vein injection of M1 or M2 
cells, we were able to change the course of the disease. This M1/M2 balance is likely 
very delicate. Further studies are needed to elucidate the direct mechanism of how 
injection of M2 cells was able to minimize aortic dilation. Furthermore, manipulation of 
the M1/M2 phenotypes in established aneurysms needs to be investigated to properly 
capture the AAA clinical scenario. Whether the goal should be to enhance the M2 
phenotype or decrease the M1 phenotype has yet to be determined. Taken together, 
targeting the M1/M2 ratio by either direct injection of M2 macrophages or 
pharmacological manipulation of the M1/M2 ratio may provide an important therapeutic 
target.  
AAA is a genetic, inflammatory, and life-threatening disease. As of yet, only 
surgical intervention and smoking cessation have been shown to be effective treatment 
strategies. No medical therapy currently exists. Until we are able to understand more 
about factors that exacerbate aneurysmal growth or the genetic predisposition of some 
patients developing AAA, mechanical intervention is the only solution. One of the 
difficulties is obtaining human AAA tissue. This difficulty is increasing due to the less 
invasive surgical techniques employed today. Finding tissue that is not toward the end 
stage of the disease and close to aneurysmal rupture is rare. Therefore, we must turn to 
animal models of disease. Animal models do well at recapitulating many of the features 
associated with human AAAs, but in the end they are just models, and each have their 
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pitfalls. However, the data obtained from animal models is necessary and can provide 
much needed insight into many of the pathways and processes associated with AAAs.  
In summary, genetic differences observed between C57Bl/6 and 129/SvEv 
indicate that baseline and activated levels of MMP-2 are vital to aneurysm formation and 
explain the differences in aneurysm susceptibility between the two models. With the 
decreased tropoelastin production and increased elastase activity seen in the 129/SvEv 
mice after aneurysm induction, there is high probability that pathways associated with 
elastin breakdown and formation are significant in the pathogenesis of AAAs. Elastin 
breakdown releases pro-inflammatory EDPs which polarize macrophages to an M1 
phenotype. Neutralization of these EDPs in vivo with BA4 minimized aortic dilation by 
reducing MMP-2 and MMP-9 activity, reducing macrophage infiltration, and altering the 
pro-inflammatory environment created by M1 macrophages. The effect of these M1 
macrophages can be altered by directly injecting anti-inflammatory M2 cells, thereby 
decreasing the M1/M2 ratio and promoting tissue repair rather than creating chronic 
inflammation. These insights can help identify genetic linkages in AAA and lead to 
prospective new strategies for medical therapy.  
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